US5192659A
(en)
*
|
1989-08-25 |
1993-03-09 |
Genetype Ag |
Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
|
US20040197775A1
(en)
*
|
1989-08-25 |
2004-10-07 |
Genetype A.G. |
Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
|
DK0570371T3
(da)
*
|
1990-07-11 |
2000-04-17 |
Genetype Ag |
Genomisk kortlægningmetode ved direkte haplotypebestemmelse ved anvendelse af intron sekvensanalyse
|
NL9002259A
(nl)
*
|
1990-10-17 |
1992-05-18 |
Eurodiagnostics B V |
Werkwijze voor het bepalen van een genotype door het vergelijken van de nucleotidensequentie van leden van een genfamilie, alsmede kit voor het opsporen van genetische variaties.
|
GB9024005D0
(en)
*
|
1990-11-05 |
1990-12-19 |
British Bio Technology |
Process for amplifying nucleic acid
|
EP0577708A4
(en)
*
|
1991-03-06 |
1998-02-04 |
Univ Minnesota |
Dna sequence-based hla typing method
|
US5424184A
(en)
*
|
1991-05-08 |
1995-06-13 |
Regents Of The University Of Minnesota |
DNA sequence-based HLA class I typing method
|
CA2081582A1
(en)
*
|
1991-11-05 |
1993-05-06 |
Teodorica Bugawan |
Methods and reagents for hla class i dna typing
|
IL103935A0
(en)
*
|
1991-12-04 |
1993-05-13 |
Du Pont |
Method for the identification of microorganisms by the utilization of directed and arbitrary dna amplification
|
US6110742A
(en)
*
|
1992-04-15 |
2000-08-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Synthetic antisense oligodeoxynucleotides targeted to AChE
|
EP0575845A3
(de)
*
|
1992-06-23 |
1998-01-07 |
F. Hoffmann-La Roche Ag |
Verfahren für Charakterisierung von HLA-DP
|
GB9301453D0
(en)
*
|
1993-01-26 |
1993-03-17 |
Clonit Spa |
Nucleotide proves
|
US6110709A
(en)
*
|
1994-03-18 |
2000-08-29 |
The General Hospital Corporation |
Cleaved amplified modified polymorphic sequence detection methods
|
CA2185902A1
(en)
*
|
1994-03-18 |
1995-09-28 |
Federick Ausubel |
Cleaved amplified rflp detection methods
|
US5599666A
(en)
*
|
1994-03-28 |
1997-02-04 |
Promega Corporation |
Allelic ladders for short tandem repeat loci
|
US5976798A
(en)
*
|
1994-03-30 |
1999-11-02 |
Mitokor |
Methods for detecting mitochondrial mutations diagnostic for Alzheimer's disease and methods for determining heteroplasmy of mitochondrial nucleic acid
|
US6027883A
(en)
*
|
1994-03-30 |
2000-02-22 |
Mitokor |
Optimal procedure for isolation of mutant mitochondrial alleles
|
AU2635295A
(en)
*
|
1994-06-13 |
1996-01-05 |
Henry Ford Health System |
A novel neuronal-neonatal gene: neuronatin
|
US6479235B1
(en)
|
1994-09-30 |
2002-11-12 |
Promega Corporation |
Multiplex amplification of short tandem repeat loci
|
US7008771B1
(en)
|
1994-09-30 |
2006-03-07 |
Promega Corporation |
Multiplex amplification of short tandem repeat loci
|
CA2118048C
(en)
*
|
1994-09-30 |
2003-04-08 |
James W. Schumm |
Multiplex amplification of short tandem repeat loci
|
US5843660A
(en)
*
|
1994-09-30 |
1998-12-01 |
Promega Corporation |
Multiplex amplification of short tandem repeat loci
|
US5545539A
(en)
*
|
1994-10-18 |
1996-08-13 |
Genzyme Corporation |
Method for nucleotide sequence amplification
|
EP0708178A1
(de)
*
|
1994-10-19 |
1996-04-24 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Motoneuronlebenserhaltungsgen: ein Gen für spinale Muskelatrophie
|
US6309843B1
(en)
|
1994-10-25 |
2001-10-30 |
The Curators Of The University Of Missouri |
Glycoprotein for use in determining endometrial receptivity
|
US20030152909A1
(en)
*
|
1994-11-16 |
2003-08-14 |
Mitrani Eduardo N. |
In vitro micro-organs, and uses related thereto
|
US5908749A
(en)
*
|
1995-02-17 |
1999-06-01 |
Tge Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for high resolution HLA typing
|
US20120160687A1
(en)
|
1995-03-17 |
2012-06-28 |
President And Fellows Of Harvard College |
Characterization of individual polymer molecules based on monomer-interface interactions
|
US6362002B1
(en)
*
|
1995-03-17 |
2002-03-26 |
President And Fellows Of Harvard College |
Characterization of individual polymer molecules based on monomer-interface interactions
|
US6653134B2
(en)
*
|
1995-03-28 |
2003-11-25 |
Cp Hahnemann University |
Isolated stromal cells for use in the treatment of diseases of the central nervous system
|
US5777093A
(en)
|
1995-05-16 |
1998-07-07 |
Ramot-University Authority For Applied Research & Industrial Development Ltd. |
cDNAs associated with ataxia-telangiectasia
|
CA2227306A1
(en)
*
|
1995-09-01 |
1997-03-27 |
Ramot-University Authority For Applied Research And Industrial Developme Nt Ltd. |
Manipulation and detection of protein phosphatase 2c - pp2c.alpha. - expression in tumor cells for cancer therapy, prevention and detection
|
DE69610933T2
(de)
*
|
1996-02-20 |
2001-05-23 |
The Perkin Elmer Corp., Foster City |
Verfahren und reagenzien zur typisierung von hla-genen der klasse i
|
US5811239A
(en)
*
|
1996-05-13 |
1998-09-22 |
Frayne Consultants |
Method for single base-pair DNA sequence variation detection
|
US6156512A
(en)
*
|
1996-05-23 |
2000-12-05 |
Promega Corp |
Allelic ladders for short tandem repeat loci
|
FR2749308B1
(fr)
*
|
1996-06-03 |
1998-07-24 |
Bio Merieux |
Sondes nucleotidiques et procede pour determiner le typage hla dqb1
|
EP0951536B1
(de)
*
|
1996-12-12 |
2007-01-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Synthetische antisense oligodeoxynukleotide und diese enthaltende pharmazeutische zusammensetzungen
|
AU5396498A
(en)
*
|
1996-12-12 |
1998-07-03 |
Visible Genetics Inc. |
Method and kit for hla class i typing
|
US6524795B1
(en)
|
1997-03-10 |
2003-02-25 |
Interleukin Genetics, Inc. |
Diagnostics for cardiovascular disorders
|
US6143496A
(en)
*
|
1997-04-17 |
2000-11-07 |
Cytonix Corporation |
Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly
|
DE69829857T2
(de)
|
1997-08-21 |
2006-02-02 |
Quark Biotech, Inc., Pleasanton |
Hypoxie-regulierte gene
|
US20030104973A1
(en)
*
|
1997-08-21 |
2003-06-05 |
Quark Biotech, Inc. |
Hypoxia-regulated genes
|
US7973156B2
(en)
*
|
1997-08-21 |
2011-07-05 |
Quark Pharmaceuticals Inc. |
Hypoxia-regulated genes
|
US6284496B1
(en)
|
1997-10-03 |
2001-09-04 |
University Of South Florida |
DNA vector for determining the presence of out-of-reading-frame mutations
|
AUPP012097A0
(en)
*
|
1997-10-30 |
1997-11-27 |
Commonwealth Scientific And Industrial Research Organisation |
Assessing lipid metabolism
|
US7687057B2
(en)
|
1998-01-09 |
2010-03-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
In vitro micro-organs, and uses related thereto
|
EP1049772A1
(de)
|
1998-01-30 |
2000-11-08 |
Genesense Technologies, Inc. |
Oligonukleotide sequenzen komplementär zur den genen von thioredoxin oder thioredoxin reductase und verfahren zur deren anwendung in der modulation von zell-wachstum
|
US20010055809A1
(en)
*
|
1998-01-30 |
2001-12-27 |
Harpal S. Mangat |
Extending tissue preservation
|
EP0953650A1
(de)
|
1998-04-20 |
1999-11-03 |
Innogenetics N.V. |
Verfahren für die HLA Typisierung
|
US6733967B1
(en)
|
1998-04-21 |
2004-05-11 |
Interleukin Genetics, Inc. |
Fetal testing for prediction of low birth weight
|
US20080206206A1
(en)
|
1998-05-07 |
2008-08-28 |
University Of South Florida |
Bone marrow-derived neuronal cells
|
US6759192B1
(en)
*
|
1998-06-05 |
2004-07-06 |
Genset S.A. |
Polymorphic markers of prostate carcinoma tumor antigen-1(PCTA-1)
|
US6344443B1
(en)
|
1998-07-08 |
2002-02-05 |
University Of South Florida |
Peptide antagonists of tumor necrosis factor alpha
|
US7605149B1
(en)
|
1998-07-13 |
2009-10-20 |
University Of South Florida |
Modulation of the phospholipase A2 pathway as a therapeutic
|
WO2000006696A2
(en)
|
1998-07-30 |
2000-02-10 |
University Of South Florida |
Method for the modulation of function of transcription factors
|
US6703228B1
(en)
|
1998-09-25 |
2004-03-09 |
Massachusetts Institute Of Technology |
Methods and products related to genotyping and DNA analysis
|
US6242223B1
(en)
*
|
1998-09-28 |
2001-06-05 |
Creighton University |
Primers for use in detecting beta-lactamases
|
EP1001037A3
(de)
*
|
1998-09-28 |
2003-10-01 |
Whitehead Institute For Biomedical Research |
Vorselektion und Isolierung eines Einzelnukleotidpolymorphismus
|
BR9914465A
(pt)
*
|
1998-09-29 |
2001-10-09 |
Gamida Cell Ltd |
Métodos para controlar a proliferação e a diferenciação de células-tronco e células progenitoras e uma composição farmacêutica para induzir a diferenciação em uma população de células
|
US6565727B1
(en)
*
|
1999-01-25 |
2003-05-20 |
Nanolytics, Inc. |
Actuators for microfluidics without moving parts
|
US20040235107A1
(en)
*
|
1999-01-29 |
2004-11-25 |
Ramot At Tel Aviv University Ltd. |
Biosynthesis of TA antibiotic
|
EP1026248A3
(de)
|
1999-01-29 |
2002-09-18 |
RAMOT UNIVERSITY AUTHORITY FOR APPLIED RESEARCH & INDUSTRIAL DEVELOPMENT LTD. |
Gencluster
|
MXPA01007820A
(es)
*
|
1999-02-04 |
2003-06-19 |
Technion Res & Dev Foundation |
Metodo y aparato para mantenimiento y expansion de celulas de tallo hemopoyeticas y/o celulas progenitoras.
|
ES2430420T3
(es)
*
|
1999-04-09 |
2013-11-20 |
Innogenetics N.V. |
Método para la amplificación de alelos HLA Clase I
|
US8017112B2
(en)
|
1999-05-14 |
2011-09-13 |
Henry Ford Health System |
Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
|
WO2000069448A1
(en)
*
|
1999-05-14 |
2000-11-23 |
Henry Ford Health System |
Bone marrow transplantation for treatment of stroke
|
US20050169896A1
(en)
*
|
1999-05-14 |
2005-08-04 |
Henry Ford Health System |
Bone marrow transplantation for treatment of stroke
|
US20070160615A1
(en)
*
|
1999-06-01 |
2007-07-12 |
Jun Tan |
Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of Alzheimer's disease
|
US6787318B1
(en)
*
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
US7534605B2
(en)
*
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
US7655423B2
(en)
*
|
1999-06-14 |
2010-02-02 |
Henry Ford Health System |
Nitric oxide donors for inducing neurogenesis
|
AU782283B2
(en)
*
|
1999-06-14 |
2005-07-14 |
Henry Ford Health System |
Nitric oxide donors for inducing neurogenesis
|
US7135498B1
(en)
|
1999-06-14 |
2006-11-14 |
Henry Ford Health System |
Nitric oxide donors for inducing neurogenesis
|
EP1192453B1
(de)
|
1999-06-22 |
2012-02-15 |
President and Fellows of Harvard College |
Bestimmung von biopolymeren entsprechend der molekularen oder atomaren skala
|
AU5423300A
(en)
*
|
1999-06-25 |
2001-01-31 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method of inducing angiogenesis by micro-organs
|
US7058517B1
(en)
|
1999-06-25 |
2006-06-06 |
Genaissance Pharmaceuticals, Inc. |
Methods for obtaining and using haplotype data
|
DE1233364T1
(de)
*
|
1999-06-25 |
2003-04-10 |
Genaissance Pharmaceuticals Inc., New Haven |
Verfahren zur herstellung und verwendung von Haplotype Daten
|
US20060127366A1
(en)
*
|
1999-06-25 |
2006-06-15 |
Mitrani Eduardo N |
Method and device for inducing biological processes by micro-organs
|
JP2003508022A
(ja)
|
1999-06-30 |
2003-03-04 |
インターリューキン ジェネティックス インコーポレイテッド |
Il−1炎症性ハプロタイプと関連する病気の診断および治療方法
|
US6875582B1
(en)
|
1999-08-19 |
2005-04-05 |
Omniscience Pharmaceuticals, Inc. |
Methods and targets of antibiotic resistance
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
AU2587701A
(en)
*
|
1999-12-27 |
2001-07-09 |
Yale University |
Identification of hla class i polymorphisms
|
US6544506B2
(en)
|
2000-01-05 |
2003-04-08 |
Yeda Research & Development Co. Ltd. |
Veto cells effective in preventing graft rejection and devoid of graft versus host potential
|
AU2001225441A1
(en)
*
|
2000-01-24 |
2001-07-31 |
Agricultural Research Organization The Volcani Center |
Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
|
ATE472601T1
(de)
|
2000-03-27 |
2010-07-15 |
Technion Res And Dev Of Founda |
Einkettige haupthistokompatibilitätskomplexe der klasse i (mhc-i), kodierende konstrukte und methoden ihrer erzeugung
|
WO2001075065A2
(en)
*
|
2000-04-03 |
2001-10-11 |
Genaissance Pharmaceuticals, Inc. |
Haplotypes of the gp1ba gene
|
US6844154B2
(en)
|
2000-04-04 |
2005-01-18 |
Polygenyx, Inc. |
High throughput methods for haplotyping
|
AU2001253366A1
(en)
*
|
2000-04-10 |
2001-10-23 |
Genaissance Pharmaceuticals, Inc. |
Haplotypes of the slc5a3 gene
|
WO2001079223A2
(en)
*
|
2000-04-12 |
2001-10-25 |
Genaissance Pharmaceuticals, Inc. |
Haplotypes of the akr1b1 gene
|
AU2001259082A1
(en)
*
|
2000-04-17 |
2001-10-30 |
Genaissance Pharmaceuticals, Inc. |
Haplotypes of the rangap1 gene
|
WO2001079235A2
(en)
*
|
2000-04-17 |
2001-10-25 |
Genaissance Pharmaceuticals, Inc. |
Haplotypes of the dnal4 gene
|
IL135884A
(en)
*
|
2000-04-30 |
2005-08-31 |
Yissum Res Dev Co |
Method for measuring non-transferrin bound iron
|
US7435541B2
(en)
*
|
2000-05-23 |
2008-10-14 |
Sequenom, Inc. |
Restriction enzyme genotyping
|
US7659054B1
(en)
|
2000-05-23 |
2010-02-09 |
Nuvelo, Inc. |
Methods for genetic analysis of DNA to detect sequence variances
|
US6931326B1
(en)
|
2000-06-26 |
2005-08-16 |
Genaissance Pharmaceuticals, Inc. |
Methods for obtaining and using haplotype data
|
HUP0300810A2
(hu)
|
2000-07-20 |
2003-08-28 |
M.G.V.S. Ltd. |
Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
PT2078531E
(pt)
|
2000-08-08 |
2012-08-06 |
Technion Res & Dev Foundation |
Composições farmacêuticas e métodos úteis para modular a angiogénese
|
US20030114410A1
(en)
*
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
AU2001286499A1
(en)
|
2000-08-16 |
2002-02-25 |
Matthew Baker |
Transfusion medicine leukodepletion filter devices as a source of genetic material for genotyping studies
|
EP1683874A3
(de)
|
2000-08-29 |
2006-10-11 |
YEDA RESEARCH AND DEVELOPMENT Co. LTD. |
Verfahren zur Isolierung von Genen, die für Proteine mit spezifischer Funktion kodieren, und zur Auslese von pharmazeutisch aktiven Wirkstoffen
|
US7632522B2
(en)
|
2000-09-28 |
2009-12-15 |
Nanocyte Inc. |
Use of stinging cells/capsules for the delivery of active agents to keratinous substances
|
US20070281037A9
(en)
*
|
2000-09-28 |
2007-12-06 |
Nanocyte Inc. |
Sterile preparations and compositions including stinging capsules and methods of producing and using same
|
WO2002026191A2
(en)
*
|
2000-09-28 |
2002-04-04 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
|
ES2425321T3
(es)
|
2000-11-17 |
2013-10-14 |
Vascular Biogenics Ltd. |
Promotores que muestran especificidad por células endoteliales y métodos de utilización de los mismos
|
US8071740B2
(en)
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
WO2002043651A2
(en)
*
|
2000-11-30 |
2002-06-06 |
Yeda Research And Development Co. Ltd. |
Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
|
EP1463811A2
(de)
*
|
2001-01-17 |
2004-10-06 |
Ramot at Tel Aviv University Ltd. |
Aus fleischfressenden pflanzen stammende chitinasen, deren kodierende polynukleotidsequenzen und verfahren zur isolierung und verwendung derselben
|
US20050202098A1
(en)
|
2001-01-31 |
2005-09-15 |
Tolaren |
Disease therapy using dying or dead cells
|
US20050031618A1
(en)
*
|
2001-01-31 |
2005-02-10 |
Dror Mevorach |
Induction of tolerance by apoptotic and/or necrotic cells
|
US7718354B2
(en)
|
2001-03-02 |
2010-05-18 |
Ibis Biosciences, Inc. |
Methods for rapid identification of pathogens in humans and animals
|
US20030027135A1
(en)
*
|
2001-03-02 |
2003-02-06 |
Ecker David J. |
Method for rapid detection and identification of bioagents
|
US20040121311A1
(en)
*
|
2002-12-06 |
2004-06-24 |
Ecker David J. |
Methods for rapid detection and identification of bioagents in livestock
|
US7226739B2
(en)
|
2001-03-02 |
2007-06-05 |
Isis Pharmaceuticals, Inc |
Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
|
US7666588B2
(en)
*
|
2001-03-02 |
2010-02-23 |
Ibis Biosciences, Inc. |
Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
|
CA2441594A1
(en)
*
|
2001-03-22 |
2002-10-03 |
Scentgene Pollination Ltd. |
Method of enhancing entomophilous
|
JP3945993B2
(ja)
*
|
2001-03-29 |
2007-07-18 |
富士通株式会社 |
半導体記憶装置
|
AUPR446801A0
(en)
|
2001-04-18 |
2001-05-17 |
University Of Queensland, The |
Novel compositions and uses therefor
|
US6770622B2
(en)
|
2001-06-08 |
2004-08-03 |
Gary A. Jarvis |
N-terminally truncated galectin-3 for use in treating cancer
|
WO2003000932A1
(en)
*
|
2001-06-20 |
2003-01-03 |
Dahlia Minc-Golomb |
Method for identifying genes that are upstream regulators of other genes of interest
|
US20030104428A1
(en)
*
|
2001-06-21 |
2003-06-05 |
President And Fellows Of Harvard College |
Method for characterization of nucleic acid molecules
|
US7217510B2
(en)
|
2001-06-26 |
2007-05-15 |
Isis Pharmaceuticals, Inc. |
Methods for providing bacterial bioagent characterizing information
|
US8073627B2
(en)
*
|
2001-06-26 |
2011-12-06 |
Ibis Biosciences, Inc. |
System for indentification of pathogens
|
IL159944A0
(en)
*
|
2001-07-19 |
2004-06-20 |
Yissum Res Dev Co |
Polypeptides having carotenoid isomerase catalytic activity, nucleic acids encoding same and uses thereof
|
US7442781B2
(en)
|
2001-08-16 |
2008-10-28 |
Urifer Ltd. |
Diagnosis, prevention and treatment of cancer
|
US20040136972A1
(en)
|
2001-09-07 |
2004-07-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
|
WO2003024462A1
(en)
*
|
2001-09-19 |
2003-03-27 |
Henry Ford Health System |
Cardiac transplantation of stem cells for the treatment of heart failure
|
MXPA04003514A
(es)
|
2001-10-19 |
2004-07-23 |
Vascular Biogenics Ltd |
Construcciones de polinucleotidos, composiciones farmaceuticas y metodos para reducir la regulacion dirigida de angionesis y terapia anticancer.
|
FR2831168B1
(fr)
*
|
2001-10-22 |
2004-02-06 |
Rocher Yves Biolog Vegetale |
Procede d'obtention d'un extrait riche en acides nucleiques a partir d'une matiere vegetale
|
WO2003048298A2
(en)
|
2001-12-05 |
2003-06-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nanoparticles containing polymeric nucleic acid homologs, pharmaceutical compositions and articles of manufacture containing same and methods of use thereof
|
US20040267458A1
(en)
*
|
2001-12-21 |
2004-12-30 |
Judson Richard S. |
Methods for obtaining and using haplotype data
|
US20050085432A1
(en)
*
|
2001-12-26 |
2005-04-21 |
Aviva Lapidot |
Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
|
IL152904A0
(en)
*
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
EP1465982A4
(de)
*
|
2002-01-25 |
2006-06-07 |
Gamida Cell Ltd |
Verfahren zur expansion von stamm- und vorläuferzellen und damit erhaltene expandierte zellpopulationen
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
US20030148288A1
(en)
*
|
2002-02-01 |
2003-08-07 |
Yi-Wei Tang |
Colorimetric genetic test for clinically significant TNF polymorphism and methods of use thereof
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
AU2003214614B2
(en)
*
|
2002-03-18 |
2008-11-20 |
Gamida-Cell Ltd. |
Methods of inducing differentiation in ex vivo expanded stem cells
|
WO2003079967A2
(en)
*
|
2002-03-26 |
2003-10-02 |
Nanocyte Inc. |
Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
|
US20040121442A1
(en)
*
|
2002-05-05 |
2004-06-24 |
Ilan Chet |
Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
|
AU2003231912A1
(en)
*
|
2002-06-12 |
2003-12-31 |
Tel Aviv Medical Center Research Development Fund |
Methods of detecting and treating prostate cancer
|
WO2004012762A2
(en)
|
2002-08-01 |
2004-02-12 |
Yeda Research And Development Co. Ltd. |
Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
|
EP1396962A1
(de)
*
|
2002-08-05 |
2004-03-10 |
Sony International (Europe) GmbH |
Busdienstschnittstelle
|
WO2004026109A2
(en)
*
|
2002-09-20 |
2004-04-01 |
Wayne State University |
Molecular targets of cancer and aging
|
US20040110205A1
(en)
*
|
2002-09-23 |
2004-06-10 |
Hui Wang |
Methods and systems for nanopore data analysis
|
US7329545B2
(en)
|
2002-09-24 |
2008-02-12 |
Duke University |
Methods for sampling a liquid flow
|
US6911132B2
(en)
|
2002-09-24 |
2005-06-28 |
Duke University |
Apparatus for manipulating droplets by electrowetting-based techniques
|
US7267981B2
(en)
|
2002-10-07 |
2007-09-11 |
Technion Research & Development Foundation Ltd. |
Human foreskin fibroblasts for culturing ES cells
|
AU2003284968A1
(en)
*
|
2002-10-25 |
2004-05-13 |
University Of South Florida |
Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
|
WO2004040252A2
(en)
|
2002-10-30 |
2004-05-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Molecules and methods using same for measuring non-transferrin bound iron
|
US20050054097A1
(en)
*
|
2002-11-17 |
2005-03-10 |
Tony Peled |
EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
|
WO2004050826A2
(en)
*
|
2002-11-29 |
2004-06-17 |
Technion Research & Development Foundation Ltd. |
Method of dynamically culturing embryonic stem cells
|
CA2508726A1
(en)
|
2002-12-06 |
2004-07-22 |
Isis Pharmaceuticals, Inc. |
Methods for rapid identification of pathogens in humans and animals
|
US7491699B2
(en)
*
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
EP2338896B1
(de)
|
2002-12-12 |
2015-02-11 |
R.B.T. (Rakuto Bio Technologies) Ltd. |
Verwendung von Ligninperoxidase zur Haut- und Haaraufhellung
|
ES2571355T3
(es)
|
2002-12-16 |
2016-05-24 |
Technion Res & Dev Foundation |
Sistema de cultivo sin células alimentadoras ni xenocontaminantes para células madre embrionarias humanas
|
US7511127B2
(en)
|
2002-12-31 |
2009-03-31 |
Cargill, Incorporated |
Compositions, methods and systems for inferring bovine breed
|
WO2004060135A2
(en)
|
2003-01-02 |
2004-07-22 |
Rappaport Family Institute For Research In The Medical Sciences |
Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients
|
EP1583713B1
(de)
|
2003-01-07 |
2009-03-25 |
Ramot at Tel Aviv University Ltd. |
Peptidenanostrukturen die fremdmaterial enthalten, und verfahren zur herstellung derselben
|
EP1599598A4
(de)
|
2003-03-04 |
2007-08-08 |
Yeda Res & Dev |
Pon-polypeptide, diese codierende polynukleotide und zusammensetzungen und verfahren unter verwendung davon
|
CA2517959A1
(en)
*
|
2003-03-07 |
2004-09-16 |
Gamida-Cell Ltd. |
Expansion of renewable stem cell populations using modulators of pi 3-kinase
|
US8017113B2
(en)
|
2003-03-12 |
2011-09-13 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions and methods for diagnosing and treating an inflammation
|
US7294701B2
(en)
*
|
2003-04-02 |
2007-11-13 |
Technion Research & Development Foundation Ltd. |
Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
|
EP2330132B1
(de)
|
2003-04-04 |
2013-08-14 |
Yeda Research and Development Co. Ltd. |
Antikörper gegen MMP2 oder MMP9 und pharmazeutische Zusammensetzungen davon zur Hemmung deren Metalloproteinaktivität
|
CA2520023C
(en)
|
2003-04-08 |
2013-02-05 |
Yeda Research And Development Co. Ltd |
Stem cells having increased sensitivity to sdf-1 and methods of generating and using same
|
FR2853551B1
(fr)
|
2003-04-09 |
2006-08-04 |
Lab Francais Du Fractionnement |
Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
|
US8046171B2
(en)
*
|
2003-04-18 |
2011-10-25 |
Ibis Biosciences, Inc. |
Methods and apparatus for genetic evaluation
|
US8057993B2
(en)
|
2003-04-26 |
2011-11-15 |
Ibis Biosciences, Inc. |
Methods for identification of coronaviruses
|
US7964343B2
(en)
*
|
2003-05-13 |
2011-06-21 |
Ibis Biosciences, Inc. |
Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
|
US8158354B2
(en)
|
2003-05-13 |
2012-04-17 |
Ibis Biosciences, Inc. |
Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
|
AU2005234725B2
(en)
*
|
2003-05-22 |
2012-02-23 |
Evogene Ltd. |
Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
|
CA2978152C
(en)
|
2003-05-22 |
2021-01-26 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
|
US7554007B2
(en)
|
2003-05-22 |
2009-06-30 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants
|
US20050020499A1
(en)
*
|
2003-05-27 |
2005-01-27 |
Bar Ilan University |
Methods of attenuating cocaine seeking behavior employing glial cell-derived neurotrophic factor (GDNF) and pharmaceutical compositions and articles of manufacture suited for use in practice of the method
|
US8129514B2
(en)
*
|
2003-06-19 |
2012-03-06 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
US7498428B2
(en)
*
|
2003-06-19 |
2009-03-03 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
JP5137400B2
(ja)
|
2003-06-30 |
2013-02-06 |
テル アヴィヴ ユニヴァーシティ フューチャー テクノロジー ディヴェロップメント エル.ピー. |
アミロイド関連疾患を診断および処置するためのペプチド、それに対する抗体、ならびにその使用方法
|
TWI372050B
(en)
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
PL2256106T3
(pl)
|
2003-07-22 |
2015-08-31 |
Astex Therapeutics Ltd |
Związki 3,4-pochodne 1h-pirazolu i ich zastosowanie jako kinazy zależne od cyklin (cdk) i modulatory kinazy syntazy glikogenu-3 (gsk-3)
|
CN101076585A
(zh)
*
|
2003-08-14 |
2007-11-21 |
生物平衡公司 |
细菌株系、包括该细菌株系的组合物和其益生菌用途
|
US7846738B2
(en)
|
2003-08-15 |
2010-12-07 |
President And Fellows Of Harvard College |
Study of polymer molecules and conformations with a nanopore
|
US20080138808A1
(en)
*
|
2003-09-11 |
2008-06-12 |
Hall Thomas A |
Methods for identification of sepsis-causing bacteria
|
US20060240412A1
(en)
*
|
2003-09-11 |
2006-10-26 |
Hall Thomas A |
Compositions for use in identification of adenoviruses
|
US8242254B2
(en)
*
|
2003-09-11 |
2012-08-14 |
Ibis Biosciences, Inc. |
Compositions for use in identification of bacteria
|
US20100035239A1
(en)
*
|
2003-09-11 |
2010-02-11 |
Isis Pharmaceuticals, Inc. |
Compositions for use in identification of bacteria
|
US8546082B2
(en)
|
2003-09-11 |
2013-10-01 |
Ibis Biosciences, Inc. |
Methods for identification of sepsis-causing bacteria
|
US8097416B2
(en)
|
2003-09-11 |
2012-01-17 |
Ibis Biosciences, Inc. |
Methods for identification of sepsis-causing bacteria
|
US7517647B2
(en)
*
|
2003-09-29 |
2009-04-14 |
New York University |
Genetic screen for bioactive peptides
|
US7625707B2
(en)
|
2003-10-02 |
2009-12-01 |
Ramot At Tel Aviv University Ltd. |
Antibacterial agents and methods of identifying and utilizing same
|
IL158287A0
(en)
|
2003-10-07 |
2004-05-12 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
ATE509034T1
(de)
|
2003-10-07 |
2011-05-15 |
Yeda Res & Dev |
Antikörper gegen nik, deren herstellung und verwendung
|
JP2007508837A
(ja)
*
|
2003-10-23 |
2007-04-12 |
ファイザー・プロダクツ・インク |
歯周疾患のためのワクチン
|
WO2005040400A2
(en)
*
|
2003-10-24 |
2005-05-06 |
Mmi Genomics, Inc. |
Methods and systems for inferring traits to manage non-beef livestock
|
CA2547459C
(en)
|
2003-11-30 |
2013-10-08 |
Yeda Research And Development Co. Ltd |
Modulators of nik-siva complex formation for treating immune disorders
|
US8163895B2
(en)
|
2003-12-05 |
2012-04-24 |
Ibis Biosciences, Inc. |
Compositions for use in identification of orthopoxviruses
|
WO2005059100A2
(en)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Methods and compositions relating to cystatin c
|
US20100221233A1
(en)
*
|
2003-12-15 |
2010-09-02 |
University Of South Florida |
Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
|
EP1722834B1
(de)
|
2003-12-22 |
2012-06-27 |
Regentis Biomaterials Ltd. |
Matrix mit natürlich vorkommendem vernetztem proteingerüst
|
WO2005061463A1
(en)
|
2003-12-23 |
2005-07-07 |
Astex Therapeutics Limited |
Pyrazole derivatives as protein kinase modulators
|
US8007847B2
(en)
*
|
2004-01-13 |
2011-08-30 |
Eytan Biderman |
Feeding formula appliance
|
US7423139B2
(en)
*
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
US20060147946A1
(en)
*
|
2004-01-27 |
2006-07-06 |
Pinchas Akiva |
Novel calcium channel variants and methods of use thereof
|
EP1758998B1
(de)
|
2004-01-30 |
2010-12-15 |
Quark Pharmaceuticals, Inc. |
Oligoribonukleotide und verfahren zu deren anwendung bei der behandlung von fibrotischen leiden und anderen krankheiten
|
US7666592B2
(en)
|
2004-02-18 |
2010-02-23 |
Ibis Biosciences, Inc. |
Methods for concurrent identification and quantification of an unknown bioagent
|
AU2005219441A1
(en)
|
2004-03-02 |
2005-09-15 |
Acceleron Pharma Inc. |
ALK7 and myostatin inhibitors and uses thereof
|
US8119336B2
(en)
|
2004-03-03 |
2012-02-21 |
Ibis Biosciences, Inc. |
Compositions for use in identification of alphaviruses
|
US8352031B2
(en)
|
2004-03-10 |
2013-01-08 |
Impulse Dynamics Nv |
Protein activity modification
|
US7238485B2
(en)
|
2004-03-23 |
2007-07-03 |
President And Fellows Of Harvard College |
Methods and apparatus for characterizing polynucleotides
|
US20050239889A1
(en)
*
|
2004-04-26 |
2005-10-27 |
Jean Gosselin |
In vivo release of endogenous anti-microbial mediators by leukotriene B4 (LTB4) administration
|
EP2458619B1
(de)
|
2004-05-24 |
2017-08-02 |
Ibis Biosciences, Inc. |
Massenspektrometrie mit selektivem Ionfilter durch digitale Schwelle
|
US20050266411A1
(en)
*
|
2004-05-25 |
2005-12-01 |
Hofstadler Steven A |
Methods for rapid forensic analysis of mitochondrial DNA
|
EP2336330B1
(de)
|
2004-06-14 |
2018-01-10 |
Evogene Ltd. |
An der Entwicklung von Pflanzenfasern beteiligte Polynukleotide und Polypeptide sowie Verfahren zur Verwendung davon
|
US8680062B2
(en)
|
2004-07-06 |
2014-03-25 |
Deliversir Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
US7811753B2
(en)
|
2004-07-14 |
2010-10-12 |
Ibis Biosciences, Inc. |
Methods for repairing degraded DNA
|
US20090156471A1
(en)
*
|
2004-07-15 |
2009-06-18 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
US20090181092A1
(en)
*
|
2004-07-16 |
2009-07-16 |
Spinal Restoration, Inc. |
Methods for Treating Joints and Discs with a Carrier Matrix and Cells
|
EP1623996A1
(de)
*
|
2004-08-06 |
2006-02-08 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Verbessertes Verfahren zur Auswahl eines Proteins von einer Bibliothek
|
US7585626B1
(en)
|
2004-08-19 |
2009-09-08 |
Quest Diagnostics Investments Incorporated |
Methods for nucleic acid amplification
|
EP1799812A4
(de)
*
|
2004-09-16 |
2009-09-09 |
Gamida Cell Ltd |
Verfahren zur ex-vivo-expansion von progenitor- und stammzellen durch gemeinsame kultivierung mit mesenchymzellen
|
WO2006035434A2
(en)
|
2004-09-28 |
2006-04-06 |
Quark Biotech, Inc. |
Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
|
EP3088528B1
(de)
|
2004-09-29 |
2019-07-03 |
Collplant Ltd. |
Kollagenproduzierende pflanzen und verfahren zur erzeugung und verwendung davon
|
US7968287B2
(en)
|
2004-10-08 |
2011-06-28 |
Medical Research Council Harvard University |
In vitro evolution in microfluidic systems
|
US7781402B2
(en)
*
|
2004-10-12 |
2010-08-24 |
Closed Loop Therapies Ltd. |
Methods and implantable devices for treating supraventricular arrhythmias
|
MY179032A
(en)
|
2004-10-25 |
2020-10-26 |
Cancer Research Tech Ltd |
Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
|
UY29177A1
(es)
|
2004-10-25 |
2006-05-31 |
Astex Therapeutics Ltd |
Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen métodos para su preparación y sus usos
|
GB0428082D0
(en)
*
|
2004-12-22 |
2005-01-26 |
Welcome Trust The Ltd |
Therapeutic compounds
|
EP1833819A1
(de)
|
2004-12-30 |
2007-09-19 |
Astex Therapeutics Limited |
Pyrazolverbindungen, die die aktivität von cdk, gsk und aurora-kinasen modulieren
|
JP2008529325A
(ja)
*
|
2005-01-16 |
2008-07-31 |
ズランゴー リミテッド |
通信ネットワークシステムおよびそれを使用するための方法
|
JP2008527563A
(ja)
*
|
2005-01-16 |
2008-07-24 |
ズランゴー リミテッド |
アイコニック通信
|
ES2552338T3
(es)
|
2005-01-21 |
2015-11-27 |
Astex Therapeutics Limited |
Compuestos farmacéuticos
|
AU2006207321B2
(en)
|
2005-01-21 |
2012-09-06 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
AU2006207933B2
(en)
*
|
2005-01-28 |
2010-11-18 |
Duke University |
Apparatuses and methods for manipulating droplets on a printed circuit board
|
WO2006080021A2
(en)
|
2005-01-31 |
2006-08-03 |
Realbio Technologies Ltd. |
Multistep reaction lateral flow capillary device
|
EP1871402B1
(de)
|
2005-02-25 |
2017-07-26 |
State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (A.R.O.), Volcani Center |
Weintraubezellkultur zur behandlung von entzündungen
|
US20060205040A1
(en)
*
|
2005-03-03 |
2006-09-14 |
Rangarajan Sampath |
Compositions for use in identification of adventitious viruses
|
US8084207B2
(en)
*
|
2005-03-03 |
2011-12-27 |
Ibis Bioscience, Inc. |
Compositions for use in identification of papillomavirus
|
TWI378090B
(en)
|
2005-04-13 |
2012-12-01 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
US8834862B2
(en)
*
|
2005-04-19 |
2014-09-16 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
|
US20090305236A1
(en)
*
|
2005-05-11 |
2009-12-10 |
Genetic Technologies Limited |
Methods of enriching fetal cells
|
WO2006126208A2
(en)
|
2005-05-26 |
2006-11-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions and methods using same for delivering agents into a target organ protected by a blood barrier
|
WO2006134602A2
(en)
|
2005-06-16 |
2006-12-21 |
Ramot At Tel Aviv University Ltd. |
Isolated cells and populations comprising same for the treatment of cns diseases
|
US20070225242A1
(en)
*
|
2005-06-21 |
2007-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for treating and preventing tumor metastasis in vivo
|
CA2614531C
(en)
*
|
2005-07-07 |
2015-06-16 |
Avraham Hochberg |
Nucleic acid agents for downregulating h19, and methods of using same
|
WO2007007325A2
(en)
|
2005-07-07 |
2007-01-18 |
Fulcrum Sp Ltd. |
Sp1 polypeptides, modified sp1 polypeptides and uses thereof
|
AU2006271181B2
(en)
|
2005-07-18 |
2012-07-12 |
Protalix Ltd. |
Mucosal or enteral administration of biologically active macromolecules
|
CA2616281C
(en)
*
|
2005-07-21 |
2014-04-22 |
Isis Pharmaceuticals, Inc. |
Methods for rapid identification and quantitation of mitochondrial dna variants
|
WO2007023491A2
(en)
|
2005-08-24 |
2007-03-01 |
Yeda Research And Development Co. Ltd. |
Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance
|
ES2664924T3
(es)
|
2005-08-26 |
2018-04-24 |
Ares Trading S.A. |
Procedimiento para la preparación del interferón beta glicosilado
|
US8476070B2
(en)
|
2005-08-29 |
2013-07-02 |
Technion Research & Development Foundation Limited |
Media for culturing stem cells
|
ATE466079T1
(de)
|
2005-09-22 |
2010-05-15 |
Yissum Res Dev Co |
Nukleinsäure konstrukten, pharmazeutische kompositionen und methoden für die behandlung von krebs
|
US20070087437A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jifan Hu |
Methods for rejuvenating cells in vitro and in vivo
|
MX350551B
(es)
|
2005-10-24 |
2017-09-08 |
Evogene Ltd |
Polipeptidos aislados, polinucleotidos que los codifican, plantas transgenicas que expresan los mismos y metodos para usarlos.
|
KR20080072748A
(ko)
|
2005-11-29 |
2008-08-06 |
가미다-셀 리미티드 |
줄기세포 귀소 및 생착을 향상시키는 방법
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
EP2363205A3
(de)
|
2006-01-11 |
2014-06-04 |
Raindance Technologies, Inc. |
Mikrofluidische Vorrichtungen Und Verfahren Zur Verwendung Bei Der Bildung Und Kontrolle Von Nanoreaktoren
|
US8541177B2
(en)
|
2006-01-13 |
2013-09-24 |
A Chan Holding B.V. |
Treatment and diagnosis of abnormal bone density with an inhibitor of the glypican-sclerostin interaction
|
EP1982450A2
(de)
*
|
2006-01-16 |
2008-10-22 |
Zlango Ltd. |
Kommunikationsnetzsystem und verfahren zu seiner verwendung
|
EP1977312A2
(de)
|
2006-01-16 |
2008-10-08 |
Zlango Ltd. |
Bildzeichenkommunikation
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
WO2007092252A2
(en)
|
2006-02-03 |
2007-08-16 |
Modigene Inc |
Long-acting polypeptides and methods of producing same
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
WO2007091254A1
(en)
|
2006-02-06 |
2007-08-16 |
Rappaport Family Institute For Research In The Medical Sciences |
Methods and kit for diagnosing t1dm
|
WO2007102146A2
(en)
|
2006-03-06 |
2007-09-13 |
Zetiq Technologies Ltd. |
Methods and compositions for identifying a cell phenotype
|
MX2008012085A
(es)
|
2006-03-23 |
2009-01-22 |
Pluristem Ltd |
Metodos para expansion de celulas y usos de celulas y medios acondicionados producidos de esta manera para terapia.
|
EP2004858A4
(de)
|
2006-03-28 |
2009-12-09 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Verfahren und kits zur bestimmung einer veranlagung zur warfarin-resistenz
|
DK3421471T3
(da)
|
2006-04-25 |
2021-06-14 |
Astex Therapeutics Ltd |
Purin- og deazapurinderivater som farmaceutiske forbindelser
|
JP2009534457A
(ja)
|
2006-04-26 |
2009-09-24 |
キャンサー・リサーチ・テクノロジー・リミテッド |
がん治療用化合物としてのイミダゾ[4,5−b]ピリジン−2−オンおよびオキサゾロ[4,5−b]ピリジン−2−オン化合物およびその類似体
|
US9562837B2
(en)
|
2006-05-11 |
2017-02-07 |
Raindance Technologies, Inc. |
Systems for handling microfludic droplets
|
EP2530167A1
(de)
|
2006-05-11 |
2012-12-05 |
Raindance Technologies, Inc. |
Mikrofluidische Vorrichtungen
|
US20070281883A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Hanna Rosenfeld |
Development of follicle stimulating hormone agonists and antagonists in fish
|
CN100526461C
(zh)
*
|
2006-07-10 |
2009-08-12 |
中国农业科学院棉花研究所 |
获得植物内含子序列扩增多态性的方法及其专用引物
|
WO2008010228A2
(en)
|
2006-07-20 |
2008-01-24 |
Yeda Research And Development Co. Ltd. |
Photosyntheticorganisms and compositions and methods of generating same
|
EP2064319B1
(de)
|
2006-08-28 |
2017-02-22 |
Yeda Research and Development Co. Ltd. |
Verfahren zur erzeugung von glia- und neuronalen zellen und verwendung davon für die behandlung medizinischer leiden des zns
|
WO2008143627A2
(en)
|
2006-09-14 |
2008-11-27 |
Ibis Biosciences, Inc. |
Targeted whole genome amplification method for identification of pathogens
|
US7888059B2
(en)
*
|
2006-10-05 |
2011-02-15 |
Yeda Research And Development Co. Ltd. |
Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
|
EP2079860B1
(de)
|
2006-10-05 |
2013-08-07 |
Technion Research & Development Foundation Ltd. |
Mikroröhrchen und herstellungsverfahren dafür
|
US20080260678A1
(en)
*
|
2006-10-10 |
2008-10-23 |
University Of Colorado |
Molecular band-aid
|
GB0620259D0
(en)
|
2006-10-12 |
2006-11-22 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
EP2073807A1
(de)
|
2006-10-12 |
2009-07-01 |
Astex Therapeutics Limited |
Pharmazeutische kombinationen
|
US8916552B2
(en)
|
2006-10-12 |
2014-12-23 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
JP2010507387A
(ja)
|
2006-10-25 |
2010-03-11 |
クアーク・ファーマスーティカルス、インコーポレイテッド |
新規のsiRNAおよびその使用方法
|
US20080131887A1
(en)
*
|
2006-11-30 |
2008-06-05 |
Stephan Dietrich A |
Genetic Analysis Systems and Methods
|
MX349479B
(es)
|
2006-12-20 |
2017-07-31 |
Evogene Ltd |
Polinucleotidos y polipeptidos involucrados en el desarrollo de fibra vegetal y metodos de uso.
|
CN101679408B
(zh)
|
2006-12-22 |
2016-04-27 |
Astex治疗学有限公司 |
作为fgfr抑制剂的双环杂环化合物
|
CN101679409B
(zh)
|
2006-12-22 |
2014-11-26 |
Astex治疗学有限公司 |
双环杂环衍生化合物、其医药组合物和其用途
|
ATE548454T1
(de)
*
|
2007-01-16 |
2012-03-15 |
Yissum Res Dev Co |
Nukleinsäurewirkstoffe zur stilllegung von h19 zwecks behandlung rheumatoider arthritis
|
WO2008093331A1
(en)
*
|
2007-01-29 |
2008-08-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Antibody conjugates for circumventing multi-drug resistance
|
EP2117616A2
(de)
|
2007-01-31 |
2009-11-18 |
Technion Research & Development Foundation Ltd. |
Elektrisch gesponnene gerüste und verfahren zu ihrer erzeugung und verwendung
|
CA2676932C
(en)
|
2007-02-01 |
2015-11-24 |
Technion Research & Development Foundation Ltd. |
Albumin fibers and fabrics and methods of generating and using same
|
WO2008097559A2
(en)
|
2007-02-06 |
2008-08-14 |
Brandeis University |
Manipulation of fluids and reactions in microfluidic systems
|
US8871471B2
(en)
*
|
2007-02-23 |
2014-10-28 |
Ibis Biosciences, Inc. |
Methods for rapid forensic DNA analysis
|
ES2662036T3
(es)
|
2007-02-28 |
2018-04-05 |
Yeda Research And Development Company Limited |
Secuencias que se dirigen al núcleo
|
GB0704932D0
(en)
|
2007-03-14 |
2007-04-25 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
US20100204266A1
(en)
*
|
2007-03-23 |
2010-08-12 |
Ibis Biosciences, INC |
Compositions for use in identification of mixed populations of bioagents
|
EP2514766A3
(de)
|
2007-03-29 |
2013-06-05 |
Technion Research & Development Foundation Ltd. |
Antikörper, Verfahren und Kits zur Diagnose und Behandlung von Melanomen
|
WO2008122980A2
(en)
*
|
2007-04-09 |
2008-10-16 |
Evogene Ltd. |
Polynucleotides, polypeptides and methods for increasing oil content, growth rate and biomass of plants
|
EP1980625A1
(de)
*
|
2007-04-10 |
2008-10-15 |
Stichting Biomedical Primate Research Center |
Mittel und Verfahren zur Haplotypisierung von MHC-DRB-Loci bei Säugern und Verwendung dafür
|
BRPI0810725A2
(pt)
*
|
2007-04-10 |
2014-10-21 |
Stichting Biomedical Primate Res Ct |
Método e uso de um método para determinar um haplótipo de drb em uma amostra, e, uso do kit.
|
EP2503008B1
(de)
|
2007-04-19 |
2015-04-01 |
Molecular Detection Inc. |
Verfahren, Zusammensetzungen und Kits zur Erkennung und Analyse von Antibiotika-resistenten Bakterien
|
US8592221B2
(en)
|
2007-04-19 |
2013-11-26 |
Brandeis University |
Manipulation of fluids, fluid components and reactions in microfluidic systems
|
US9556210B2
(en)
|
2007-04-23 |
2017-01-31 |
Sabag-Rfa Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
US9156865B2
(en)
|
2007-04-23 |
2015-10-13 |
Deliversir Ltd |
System for delivering therapeutic agents into living cells and cells nuclei
|
PT2144633E
(pt)
*
|
2007-04-23 |
2014-10-27 |
Deliversir Ltd |
Um sistema para a administração de agentes terapêuticos em células vivas e núcleos de células
|
WO2008132753A2
(en)
|
2007-05-01 |
2008-11-06 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for detecting fetal cells in the maternal blood
|
SG187447A1
(en)
|
2007-05-07 |
2013-02-28 |
Protalix Ltd |
Large scale disposable bioreactor
|
US9598724B2
(en)
|
2007-06-01 |
2017-03-21 |
Ibis Biosciences, Inc. |
Methods and compositions for multiple displacement amplification of nucleic acids
|
CA2963857A1
(en)
|
2007-06-04 |
2008-12-11 |
Ben-Gurion University Of The Negev Research And Development Authority |
Tri-aryl compounds and compositions comprising the same
|
US20090004662A1
(en)
|
2007-06-18 |
2009-01-01 |
Applera Corporation |
Method and compositions for nucleic acid amplification
|
WO2009007980A1
(en)
|
2007-07-11 |
2009-01-15 |
Yeda Research And Development Co. Ltd. |
Nucleic acid construct systems capable of diagnosing or treating a cell state
|
CA2696833A1
(en)
|
2007-07-15 |
2009-01-22 |
Yitzchak Hillman |
Disease treatment via antimicrobial peptides or their inhibitors
|
IL184627A0
(en)
|
2007-07-15 |
2008-12-29 |
Technion Res & Dev Foundation |
Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
|
AU2008278654B2
(en)
|
2007-07-24 |
2014-06-05 |
Evogene Ltd. |
Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance and/or biomass and/or yield in plants expressing same
|
ES2402334T3
(es)
*
|
2007-08-02 |
2013-04-30 |
Gilead Biologics, Inc |
Procedimientos y composiciones para el tratamiento y el diagnóstico de la fibrosis
|
WO2009021233A2
(en)
*
|
2007-08-09 |
2009-02-12 |
Advanced Liquid Logic, Inc. |
Pcb droplet actuator fabrication
|
MX2010001657A
(es)
|
2007-08-15 |
2010-03-15 |
Yeda Res & Dev |
Reguladores de mmp-9 y usos de los mismos.
|
US20110123481A1
(en)
|
2007-08-16 |
2011-05-26 |
Remedor Biomed Ltd. |
Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications
|
EP2195650B1
(de)
|
2007-09-12 |
2016-07-06 |
Yeda Research And Development Company Ltd. |
Verfahren zur behandlung von tumoren an immunprivilegierten stellen
|
EP2200622B2
(de)
|
2007-09-19 |
2015-07-29 |
Pluristem Ltd. |
Haftende zellen von fett- oder plazenta-gewebe und ihre verwendung in der therapie
|
GB0720038D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New compounds
|
GB0720041D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New Compounds
|
US20100086914A1
(en)
*
|
2008-10-03 |
2010-04-08 |
Roche Molecular Systems, Inc. |
High resolution, high throughput hla genotyping by clonal sequencing
|
ES2620487T3
(es)
|
2007-10-19 |
2017-06-28 |
Rappaport Family Institute For Research In The Medical Sciences |
Composiciones que comprenden semaforinas para uso en el tratamiento del cáncer
|
TW200930818A
(en)
|
2007-10-30 |
2009-07-16 |
Applied Biosystems |
Method and kits for multiplex amplification of short tandem repeat loci
|
US8431158B2
(en)
|
2007-11-26 |
2013-04-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions comprising fibrous polypeptides and polysaccharides
|
AU2008337286B2
(en)
|
2007-12-19 |
2014-08-07 |
Cancer Research Technology Limited |
Pyrido[2,3-b]pyrazine-8-substituted compounds and their use
|
AU2008344935C1
(en)
|
2007-12-27 |
2016-07-14 |
Evogene Ltd. |
Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants
|
US8185323B1
(en)
|
2008-01-06 |
2012-05-22 |
Degen Zhuo |
Method of identifying exons and introns and diagnostic uses thereof
|
GB0806527D0
(en)
|
2008-04-11 |
2008-05-14 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
PL2288376T3
(pl)
|
2008-04-18 |
2016-07-29 |
Collplant Ltd |
Sposoby generowania i wykorzystywania prokolagenu
|
CA2721372A1
(en)
|
2008-04-21 |
2009-10-29 |
Danziger Innovations Ltd. |
Plant viral expression vectors and use of same for generating genotypic variations in plant genomes
|
GB0807609D0
(en)
*
|
2008-04-25 |
2008-06-04 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
WO2009141824A2
(en)
*
|
2008-05-22 |
2009-11-26 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficieny
|
WO2009144720A1
(en)
|
2008-05-27 |
2009-12-03 |
Pluristem Ltd. |
Methods of treating inflammatory colon diseases
|
US8722348B2
(en)
|
2008-05-28 |
2014-05-13 |
Wayne State University |
Method and composition for a protein transduction technology and its applications
|
ES2688945T3
(es)
|
2008-05-28 |
2018-11-07 |
Ramot At Tel-Aviv University Ltd. |
Células madre mesenquimales para el tratamiento de enfermedades del SNC
|
WO2009147684A2
(en)
|
2008-06-06 |
2009-12-10 |
Quark Pharmaceuticals, Inc. |
Compositions and methods for treatment of ear disorders
|
GB0810902D0
(en)
|
2008-06-13 |
2008-07-23 |
Astex Therapeutics Ltd |
New compounds
|
EP2300607A2
(de)
|
2008-06-26 |
2011-03-30 |
Spectrum Health Innovations, LLC |
Verfahren zur behandlung und verhinderung von strahlungsschäden mithilfe genetisch modifizierter mesenchymaler stammzellen
|
US20110082191A1
(en)
*
|
2008-06-26 |
2011-04-07 |
Spectrum Health Innovations, LLC |
Method for treating or preventing radiation damage by in vivo gene therapy
|
EP2326419B1
(de)
|
2008-06-29 |
2021-04-07 |
Realbio Technologies Ltd. |
Flüssigkeitstransfervorrichtung, die besonders gut als einfangvorrichtung in einem biologischen assayverfahren geeignet ist
|
US12038438B2
(en)
|
2008-07-18 |
2024-07-16 |
Bio-Rad Laboratories, Inc. |
Enzyme quantification
|
EP4047367A1
(de)
|
2008-07-18 |
2022-08-24 |
Bio-Rad Laboratories, Inc. |
Verfahren zum nachweis von zielanalyten unter verwendung von tropfenbibliotheken
|
AU2009279434A1
(en)
*
|
2008-08-08 |
2010-02-11 |
Navigenics, Inc. |
Methods and systems for personalized action plans
|
EP2657342B1
(de)
|
2008-08-08 |
2015-11-18 |
Genisphere, LLC |
Vor Nukleaseabbruch geschützte DNA-Dendrimere
|
AU2009283785B2
(en)
|
2008-08-18 |
2016-01-28 |
Evogene Ltd. |
Isolated polypeptides and polynucleotides useful for increasing nitrogen use efficiency, abiotic stress tolerance, yield and biomass in plants
|
ES2522346T3
(es)
|
2008-08-22 |
2014-11-14 |
Novartis Ag |
Compuestos de pirrolopirimidina como inhibidores de CDK
|
AU2009288781B2
(en)
|
2008-09-02 |
2015-01-29 |
Pluri Biotech Ltd |
Adherent cells from placenta tissue and use thereof in therapy
|
US8367392B2
(en)
*
|
2008-09-05 |
2013-02-05 |
Transalgae Ltd. |
Genetic transformation of algal and cyanobacteria cells by microporation
|
US20110305682A1
(en)
|
2008-09-11 |
2011-12-15 |
Ben Gurion University Of The Negev Research And Development Authority |
Compositions and Methods for Treating S. Pneumonia Infection
|
BRPI0919020A2
(pt)
|
2008-09-12 |
2017-08-22 |
Univ South Florida |
Uso de células de linhagem monocitária enriquecidas para tratar isquemia e para tratar angina pectoris
|
AU2009291577A1
(en)
*
|
2008-09-12 |
2010-03-18 |
Navigenics, Inc. |
Methods and systems for incorporating multiple environmental and genetic risk factors
|
US8550694B2
(en)
|
2008-09-16 |
2013-10-08 |
Ibis Biosciences, Inc. |
Mixing cartridges, mixing stations, and related kits, systems, and methods
|
EP2344893B1
(de)
|
2008-09-16 |
2014-10-15 |
Ibis Biosciences, Inc. |
Mikroplatten-handhabungssysteme und verfahren
|
US8148163B2
(en)
|
2008-09-16 |
2012-04-03 |
Ibis Biosciences, Inc. |
Sample processing units, systems, and related methods
|
ES2690348T3
(es)
|
2008-09-24 |
2018-11-20 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Péptidos y composiciones para la prevención de la adhesión celular y métodos de uso de los mismos
|
CA2736729A1
(en)
|
2008-09-29 |
2010-04-01 |
Ben Gurion University Of The Negev Research And Development Authority |
Amyloid beta-peptides and methods of use thereof
|
US20100261189A1
(en)
*
|
2008-10-03 |
2010-10-14 |
Roche Molecular Systems, Inc. |
System and method for detection of HLA Variants
|
US8921658B2
(en)
|
2008-10-30 |
2014-12-30 |
Evogene Ltd. |
Isolated polynucleotides encoding a MAP65 polypeptide and methods of using same for increasing plant yield
|
US20110229892A1
(en)
|
2008-11-17 |
2011-09-22 |
Yehuda G Assaraf |
Method for predicting a patient's responsiveness to anti-folate therapy
|
WO2010058396A1
(en)
|
2008-11-19 |
2010-05-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
A cd44vra antibody and diagnostic and therapeutic methods using same
|
WO2010061383A1
(en)
|
2008-11-26 |
2010-06-03 |
Biodalia Microbiological Technologies Ltd. |
A method of in-situ enrichment of foods with fructan
|
WO2010064231A1
(en)
|
2008-12-02 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods of analyzing a-i rna editing and nucleic acid constructs capable of same
|
US20120014927A1
(en)
|
2008-12-03 |
2012-01-19 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for determining predisposition to cancer
|
EP2373301B1
(de)
|
2008-12-05 |
2013-11-06 |
Yeda Research and Development Co. Ltd. |
Verfahren zur diagnose der motorischen nervenerkrankungen
|
EP2808402A3
(de)
|
2008-12-29 |
2015-03-25 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Verfahren zur Vorhersage des Ansprechens auf Interferonbehandlung
|
AR074925A1
(es)
|
2008-12-29 |
2011-02-23 |
Evogene Ltd |
Polinucleotidos, polipeptidos codificados, y metodos para utilizarlos para modular la tolerancia al estres abiotico, biomasa y/o rendimiento en plantas que los expresan
|
CA2967412C
(en)
|
2008-12-29 |
2018-07-17 |
Tel Hashomer Medical Research, Infrastructure And Services Ltd. |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
WO2010076794A1
(en)
|
2008-12-31 |
2010-07-08 |
Technion Research & Development Foundation Ltd. |
Method of denitrifying brine and systems capable of same
|
WO2010080769A2
(en)
|
2009-01-06 |
2010-07-15 |
Arresto Biosciences, Inc. |
Chemotherapeutic methods and compositions
|
IL196820A0
(en)
|
2009-02-01 |
2009-11-18 |
Yissum Res Dev Co |
Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
|
US8691760B2
(en)
|
2009-02-02 |
2014-04-08 |
Ramot At Tel-Aviv University |
Peptides, pharmaceutical compositions comprising same and uses thereof
|
WO2010089707A1
(en)
|
2009-02-04 |
2010-08-12 |
Yeda Research And Development Co. Ltd. |
Methods and kits for determining sensitivity or resistance of prostate cancer to radiation therapy
|
IL313131A
(en)
|
2009-02-11 |
2024-07-01 |
Caris Mpi Inc |
Molecular characterization of tumors
|
US8158936B2
(en)
|
2009-02-12 |
2012-04-17 |
Ibis Biosciences, Inc. |
Ionization probe assemblies
|
WO2010097793A2
(en)
|
2009-02-26 |
2010-09-02 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Isolated populations of renal stem cells and methods of isolating and using same
|
MX342016B
(es)
|
2009-03-02 |
2016-09-09 |
Evogene Ltd |
Polinucleotidos y polipeptidos aislados, y metodos para usarlos para incrementar el rendimiento de una planta y/o caracteristicas agricolas.
|
DK2406279T3
(en)
|
2009-03-09 |
2016-04-25 |
Univ Ramot |
Compositions for prevention and treatment of neurodegenerative diseases
|
WO2010103517A1
(en)
|
2009-03-12 |
2010-09-16 |
Rappaport Family Institute For Research In The Medical Sciences |
Soluble compositions for the treatment of cxcr3-ligand associated diseases
|
DK2414542T3
(da)
|
2009-03-30 |
2017-11-27 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Fremgangsmåder til forudsigelse af klinisk forløb for og behandling af multipel sklerose
|
AU2010231514A1
(en)
|
2009-04-01 |
2011-11-03 |
Rappaport Family Institute For Research In The Medical Sciences |
A method of regulating proliferation and differentiation of keratinocytes
|
WO2010116375A1
(en)
|
2009-04-08 |
2010-10-14 |
Yeda Research And Development Co. Ltd. |
Isolated peptides for regulating apoptosis
|
GB0906470D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
EP2421955A4
(de)
|
2009-04-21 |
2012-10-10 |
Genetic Technologies Ltd |
Verfahren zur gewinnung von fötalem genmaterial
|
WO2010125571A1
(en)
|
2009-04-30 |
2010-11-04 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Anti ceacam1 antibodies and methods of using same
|
CN102576024B
(zh)
|
2009-05-19 |
2016-10-26 |
泽蒂克科技有限公司 |
宫颈癌细胞和/或组织的鉴别染色的试剂盒和方法
|
GB0908905D0
(en)
|
2009-05-26 |
2009-07-01 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
CN102639146A
(zh)
|
2009-05-27 |
2012-08-15 |
耶达研究及发展有限公司 |
蛋白酶体抑制剂及其用途
|
WO2010137013A1
(en)
|
2009-05-27 |
2010-12-02 |
Ramot At Tel Aviv University Ltd. |
Crystallized photosystem i units from the pea plant and their use in solid state devices
|
US20120078163A1
(en)
|
2009-05-27 |
2012-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of generating connective tissue
|
WO2010137020A1
(en)
|
2009-05-28 |
2010-12-02 |
Yeda Research And Development Co. Ltd. |
Methods of treating inflammation
|
EP2440214A4
(de)
|
2009-06-08 |
2013-07-31 |
Quark Pharmaceuticals Inc |
Verfahren zur behandlung chronischer nierenkrankheiten
|
EP3238534B1
(de)
|
2009-06-10 |
2019-11-13 |
Evogene Ltd. |
Isolierte polynukleotide und polypeptide sowie verfahren zur verwendung davon zur erhöhung der stickstoffverwendungseffizienz, des ertrags, der wachstumsrate, der stärke, der biomasse, des ölgehalts und/oder der abiotischen stresstoleranz
|
IN2012DN00715A
(de)
|
2009-06-24 |
2015-06-19 |
Health Corp Rambam |
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
WO2011004379A1
(en)
|
2009-07-10 |
2011-01-13 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Compositions and methods for treating cancer
|
EP2454000A4
(de)
|
2009-07-17 |
2016-08-10 |
Ibis Biosciences Inc |
Systeme zur identifizierung von biowirkstoffen
|
WO2011008971A1
(en)
*
|
2009-07-17 |
2011-01-20 |
Ibis Biosciences, Inc. |
Lift and mount apparatus
|
ES2753986T3
(es)
|
2009-07-21 |
2020-04-15 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Un método de diagnóstico de cáncer
|
GB0913442D0
(en)
|
2009-07-31 |
2009-09-16 |
Univ Ramot |
Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
|
EP2467470A2
(de)
|
2009-08-17 |
2012-06-27 |
Technion Research & Development Foundation Ltd. |
Pericytvorläuferzellen sowie verfahren zu ihrer herstellung und verwendung
|
CN102711820A
(zh)
*
|
2009-08-21 |
2012-10-03 |
吉联亚生物科技有限公司 |
治疗肺纤维化疾病的方法和组合物
|
US20110044907A1
(en)
*
|
2009-08-21 |
2011-02-24 |
Derek Marshall |
In vivo screening assays
|
CA2770276A1
(en)
|
2009-08-21 |
2012-02-24 |
Beeologics, Inc. |
Preventing and curing beneficial insect diseases via plant transcribed molecules
|
WO2011022709A1
(en)
*
|
2009-08-21 |
2011-02-24 |
Arresto Biosciences, Inc |
In vitro screening assays
|
EP2467396A4
(de)
|
2009-08-21 |
2012-12-26 |
Gilead Biologics Inc |
Katalytische domänen aus lysyl-oxidase und loxl2
|
US20110076272A1
(en)
*
|
2009-08-21 |
2011-03-31 |
Victoria Smith |
Therapeutic methods and compositions
|
US9642817B2
(en)
|
2009-08-27 |
2017-05-09 |
Technion Research & Development Foundation Limited |
Liposomal compositions and uses of same
|
US9610331B2
(en)
|
2009-09-08 |
2017-04-04 |
Yeda Research And Development Co. Ltd. |
Methods for hematopoietic precursor mobilization
|
EP2475784A1
(de)
|
2009-09-08 |
2012-07-18 |
Ramot at Tel-Aviv University Ltd. |
Verfahren zur diagnose von amyotropher lateralsklerose (als)
|
WO2011030329A1
(en)
|
2009-09-10 |
2011-03-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating tumors
|
WO2011033506A2
(en)
|
2009-09-17 |
2011-03-24 |
Yeda Research And Development Co. Ltd. |
Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
US8735124B2
(en)
|
2009-09-17 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
BR112012006005A2
(pt)
|
2009-09-17 |
2017-09-19 |
Univ Ramot |
"peptídeos no tratamento de transtorno associados ao estresse oxidativo"
|
US20110081706A1
(en)
*
|
2009-10-02 |
2011-04-07 |
TransAlgae Ltd |
Method and system for efficient harvesting of microalgae and cyanobacteria
|
US20110091882A1
(en)
*
|
2009-10-02 |
2011-04-21 |
Ibis Biosciences, Inc. |
Determination of methylation status of polynucleotides
|
EP3272869B1
(de)
|
2009-10-14 |
2020-06-24 |
Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. |
Zusammensetzungen zur bekämpfung von varroa-milben bei bienen
|
US8962584B2
(en)
|
2009-10-14 |
2015-02-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Compositions for controlling Varroa mites in bees
|
EP2957641B1
(de)
*
|
2009-10-15 |
2017-05-17 |
Ibis Biosciences, Inc. |
Multiple-displacement-amplifikation
|
US9476060B2
(en)
|
2009-10-21 |
2016-10-25 |
Danziger Innovations Ltd. |
Generating genotypic variations in plant genomes by gamete infection
|
AU2010315400B2
(en)
|
2009-10-27 |
2016-07-21 |
Caris Mpi, Inc. |
Molecular profiling for personalized medicine
|
IL201999A
(en)
|
2009-11-08 |
2017-10-31 |
Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel |
A knockout mouse of the 1 – mo gene, a gene associated with morbidly extreme obesity
|
WO2011058557A1
(en)
|
2009-11-12 |
2011-05-19 |
Ramot At Tel-Aviv University Ltd. |
Compositions comprising pedf and uses of same in the treatment and prevention of ovary-related syndromes
|
WO2011058555A1
(en)
|
2009-11-12 |
2011-05-19 |
Yeda Research And Development Co. Ltd. |
A method of editing dna in a cell and constructs capable of same
|
DK3633025T3
(da)
|
2009-11-12 |
2022-12-12 |
Technion Res & Dev Foundation |
Dyrkningsmedier, cellekulturer og metoder til dyrkning af pluripotente stamceller i en udifferentieret tilstand
|
WO2011061736A1
(en)
|
2009-11-17 |
2011-05-26 |
Protalix Ltd. |
Alkaline alpha galactosidase for the treatment of fabry disease
|
EP2504472A1
(de)
|
2009-11-24 |
2012-10-03 |
Collplant Ltd. |
Verfahren zur erzeugung von kollagenfasern
|
TW201124160A
(en)
|
2009-11-26 |
2011-07-16 |
Quark Pharmaceuticals Inc |
SiRNA compounds comprising terminal substitutions
|
NZ600651A
(en)
|
2009-11-30 |
2014-07-25 |
Pluristem Ltd |
Adherent cells from placenta and use of same in disease treatment
|
WO2011067745A2
(en)
|
2009-12-06 |
2011-06-09 |
Rosetta Green Ltd. |
Compositions and methods for enhancing plants resistance to abiotic stress
|
EP2862929B1
(de)
|
2009-12-09 |
2017-09-06 |
Quark Pharmaceuticals, Inc. |
Zusammensetzungen und Verfahren zur Behandlung von Erkrankungen, Störungen oder Läsionen des ZNS
|
AU2010337936B2
(en)
|
2009-12-28 |
2016-06-23 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
|
EP3785712A1
(de)
|
2009-12-29 |
2021-03-03 |
Gamida-Cell Ltd. |
Verfahren zur steigerung der proliferation und aktivität natürlicher killerzellen
|
US9567605B2
(en)
|
2010-01-05 |
2017-02-14 |
Vascular Biogenics Ltd. |
Methods for use of a specific anti-angiogenic adenoviral agent
|
WO2011084193A1
(en)
|
2010-01-07 |
2011-07-14 |
Quark Pharmaceuticals, Inc. |
Oligonucleotide compounds comprising non-nucleotide overhangs
|
US20130052165A1
(en)
|
2010-01-12 |
2013-02-28 |
Livnat Bangio |
Methods of Producing Adenovirus Vectors and Viral Preparations Generated Thereby
|
CA2787311C
(en)
|
2010-01-27 |
2017-08-15 |
Yeda Research And Development Co. Ltd. |
Antibodies that inhibit metalloproteins
|
US8815896B2
(en)
|
2010-02-01 |
2014-08-26 |
The Institute Of Cancer Research: Royal Cancer Hospital |
1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy
|
RU2549684C2
(ru)
|
2010-02-04 |
2015-04-27 |
Джилид Байолоджикс, Инк. |
Антитела, связывающиеся с лизилоксидазоподобным ферментом-2 (loxl2), и способы их применения
|
US9410131B2
(en)
|
2010-02-11 |
2016-08-09 |
Yeda Research And Development Co. Ltd. |
Enzymatic systems for carbon fixation and methods of generating same
|
US10351905B2
(en)
|
2010-02-12 |
2019-07-16 |
Bio-Rad Laboratories, Inc. |
Digital analyte analysis
|
US8535889B2
(en)
|
2010-02-12 |
2013-09-17 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US9366632B2
(en)
|
2010-02-12 |
2016-06-14 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US9399797B2
(en)
|
2010-02-12 |
2016-07-26 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
WO2011104708A2
(en)
|
2010-02-24 |
2011-09-01 |
Ben Gurion University Of The Negev Research And Development Authority |
Methods for inhibiting necrosis
|
WO2011107939A1
(en)
|
2010-03-01 |
2011-09-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of predicting efficacy of an anti-vegfa treatment for solid tumors
|
WO2011107994A1
(en)
|
2010-03-04 |
2011-09-09 |
Yeda Research And Development Co. Ltd. |
Methods of measuring protein stability
|
US9267142B2
(en)
|
2010-03-08 |
2016-02-23 |
Yeda Research And Development Co. Ltd. |
Recombinant protein production in heterologous systems
|
WO2011112570A1
(en)
|
2010-03-08 |
2011-09-15 |
Monsanto Technology Llc |
Polynucleotide molecules for gene regulation in plants
|
WO2011111050A2
(en)
|
2010-03-11 |
2011-09-15 |
Jacob Edrei |
Methods of generating hydrogen
|
EP2556085A2
(de)
|
2010-04-05 |
2013-02-13 |
Bar-Ilan University |
Proteaseaktivierbare, porenbildende polypeptide
|
WO2011128897A1
(en)
|
2010-04-12 |
2011-10-20 |
Technion Research & Development Foundation Ltd. |
Populations of pancreatic progenitor cells and methods of isolating and using same
|
US9458438B2
(en)
|
2010-04-12 |
2016-10-04 |
Ben Gurion University Of The Negev Research And Development Authority |
Sulfotransferase of a red microalga and uses thereof
|
US9518988B2
(en)
|
2010-04-18 |
2016-12-13 |
Yeda Research And Development Co. Ltd. |
Antibodies and methods of using same for treating ErbB/ErbB ligands associated diseases
|
CA2797200C
(en)
|
2010-04-28 |
2020-03-31 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
|
GB201007286D0
(en)
|
2010-04-30 |
2010-06-16 |
Astex Therapeutics Ltd |
New compounds
|
US20130053277A1
(en)
|
2010-05-04 |
2013-02-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of identifying inhibitors of polypeptides-of-interest
|
EP2566500B1
(de)
|
2010-05-05 |
2017-04-12 |
Rappaport Family Institute for Research in the Medical Sciences |
Ccl1 zur verwendung für therapeutische zwecke
|
IL208820A0
(en)
|
2010-10-19 |
2011-01-31 |
Rachel Teitelbaum |
Biologic female contraceptives
|
EP2569417B1
(de)
|
2010-05-13 |
2018-04-18 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Isolierte populationen adulter nierenzellen sowie verfahren zu ihrer isolierung und verwendung
|
US9624285B2
(en)
|
2010-06-03 |
2017-04-18 |
Ramot a Tel-Aviv University Ltd. |
Methods of treating diabetes and compositions capable of same
|
WO2011154940A1
(en)
|
2010-06-07 |
2011-12-15 |
Osnat Ashur-Fabian |
Methods and kits for diagnosing conditions related to hypoxia
|
EP2580588B1
(de)
|
2010-06-08 |
2014-09-24 |
President and Fellows of Harvard College |
Nanoporen-vorrichtung mit graphengetragener künstlicher lipidmembran
|
US9187787B2
(en)
|
2010-06-16 |
2015-11-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of diagnosing and treating cancer
|
BR112012032126A2
(pt)
|
2010-06-16 |
2017-10-17 |
Futuragene Israel Ltd Empresa Isralense |
polinucleotídeo isolado, estrutura de ácido nucléico, sistema de estrutura de ácido nucléico, polipeptídeo isolado, planta, composição inseticida, e método para controlar ou exterminar um inseto
|
NZ604094A
(en)
|
2010-06-24 |
2014-11-28 |
Quark Pharmaceuticals Inc |
Double stranded rna compounds to rhoa and use thereof
|
US9512188B2
(en)
|
2010-07-12 |
2016-12-06 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Isolated polynucleotides and methods and plants using same for regulating plant acidity
|
CN103108955B
(zh)
|
2010-07-15 |
2015-11-25 |
工业研究与发展基金会有限公司 |
用于提高植物中非生物胁迫耐受性的核酸构建体
|
EP2593551B1
(de)
|
2010-07-15 |
2016-09-14 |
Technion Research & Development Foundation Ltd. |
Isolierte hochaffine einheiten mit t-zell-rezeptorähnlicher spezifität gegenüber nativen komplexen der mhc-klasse ii und autoantigenen gad-peptiden
|
EP2593480A2
(de)
|
2010-07-15 |
2013-05-22 |
Technion Research & Development Foundation Ltd. |
Antikörper mit t-zell-rezeptorähnlicher spezifität gegenüber nativen komplexen der mhc-klasse ii und diabetes-assoziierten autoantigenen peptiden
|
WO2012011113A2
(en)
|
2010-07-22 |
2012-01-26 |
Shai Yarkoni |
Regulatory immune cells with enhanced targeted cell death effect
|
WO2012014207A2
(en)
|
2010-07-27 |
2012-02-02 |
Technion Research & Development Foundation Ltd. |
Method for generating induced pluripotent stem cells from keratinocytes derived from plucked hair follicles
|
WO2012014208A2
(en)
|
2010-07-27 |
2012-02-02 |
Yeda Research And Development Co. Ltd. |
Methods and systems for assessing clonality of cell cultures
|
US9144585B2
(en)
|
2010-07-27 |
2015-09-29 |
Technion Research & Development Foundation Limited |
Isolated mesenchymal progenitor cells and extracellular matrix produced thereby
|
EP2600885A2
(de)
|
2010-08-04 |
2013-06-12 |
Ramot at Tel Aviv University, Ltd. |
Verfahren zur behandlung von autoimmunerkrankungen des zentralnervensystems (zns) und neurodegenerativen erkrankungen
|
WO2012025914A1
(en)
|
2010-08-22 |
2012-03-01 |
Ramot At Tel-Aviv University Ltd. |
Induced pluripotent stem cells derived from human pancreatic beta cells
|
WO2012025925A1
(en)
|
2010-08-24 |
2012-03-01 |
Rappaport Family Institute For Research In The Medical Sciences |
Methods of improving transplantation using sdf-1alpha
|
AR082530A1
(es)
|
2010-08-30 |
2012-12-12 |
Evogene Ltd |
Polinucleotidos y polipeptidos aislados, y metodos para utilizarlos para aumentar la eficacia en el uso de nitrogeno, rendimiento, tasa de crecimiento, vigor, biomasa, contenido de aceite y/o tolerancia al estres abiotico
|
US20130164288A1
(en)
|
2010-09-07 |
2013-06-27 |
Protalix Ltd. |
Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
|
WO2012032519A2
(en)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of diagnosing parkinson's disease
|
WO2012032510A1
(en)
|
2010-09-07 |
2012-03-15 |
Yeda Research And Development Co. Ltd. |
Primers for amplifying dna and methods of selecting same
|
SG10202109393RA
(en)
|
2010-09-07 |
2021-10-28 |
Technion Res & Dev Foundation |
Novel Methods And Culture Media For Culturing Pluripotent Stem Cells
|
ES2589678T3
(es)
|
2010-09-08 |
2016-11-15 |
Yeda Research And Development Co. Ltd. |
Uso de linfocitos T de memoria central anti-terceros para el tratamiento anti-leucemia/linfoma
|
WO2012032525A2
(en)
|
2010-09-08 |
2012-03-15 |
Yeda Research And Development Co. Ltd. |
An immunosuppressive drug combination for a stable and long term engraftment
|
WO2012035539A1
(en)
|
2010-09-15 |
2012-03-22 |
Ramot At Tel-Aviv University Ltd. |
Methods of expanding and redifferentiating islet beta cells
|
WO2012038956A1
(en)
|
2010-09-20 |
2012-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating neurodegenerative diseases
|
WO2012045012A2
(en)
|
2010-09-30 |
2012-04-05 |
Raindance Technologies, Inc. |
Sandwich assays in droplets
|
EP3075396A1
(de)
|
2010-10-17 |
2016-10-05 |
Yeda Research and Development Co. Ltd. |
Verfahren und zusammensetzungen zur behandlung von insulinassoziierten erkrankungen
|
WO2012052878A1
(en)
|
2010-10-19 |
2012-04-26 |
Vascular Biogenics Ltd. |
Isolated polynucleotides and nucleic acid constructs for directing expression of a gene-of-interest in cells
|
US20130216603A1
(en)
|
2010-10-27 |
2013-08-22 |
Nanocyte (Israel) Ltd. |
Pharmaceutical compositions and delivery devices comprising stinging cells or capsules
|
WO2012056455A1
(en)
|
2010-10-28 |
2012-05-03 |
Yeda Research And Development Co. Ltd. |
Methods of generating antibodies to metalloenzymes
|
CA2815927A1
(en)
|
2010-11-03 |
2012-05-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusale M Ltd. |
Transgenic plants with improved saccharification yields and methods of generating same
|
EP2635105B1
(de)
|
2010-11-04 |
2017-12-20 |
Ben-Gurion University of The Negev Research and Development Authority |
Acyl-coa: diacylglyzerin-acyltransferase-1-ähnliches gen (ptdgat1) und verwendungen davon
|
CA2817830A1
(en)
|
2010-11-15 |
2012-05-24 |
Ramot At Tel Aviv University Ltd. |
Dipeptide analogs for treating conditions associated with amyloid fibril formation
|
US20120122093A1
(en)
|
2010-11-15 |
2012-05-17 |
Life Technologies Corporation |
Methods and kits for multiplex amplification of short tandem repeat loci
|
US10117895B2
(en)
|
2010-11-17 |
2018-11-06 |
Ben-Gurion University Of The Negev Research And Development Authority |
T-cell therapy to neurodegenerative diseases
|
GB201020179D0
(en)
|
2010-11-29 |
2011-01-12 |
Astex Therapeutics Ltd |
New compounds
|
JP6139410B2
(ja)
|
2010-12-02 |
2017-05-31 |
テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド |
角膜細胞の作製方法および該角膜細胞を含む細胞集団
|
CA2818024C
(en)
|
2010-12-06 |
2019-09-24 |
Quark Pharmaceuticals, Inc. |
Double stranded oligonucleotide compounds comprising positional modifications
|
AU2011253984A1
(en)
|
2010-12-07 |
2012-06-28 |
Biobalance Llc |
Method For Identifying E. Coli M-17
|
WO2012081029A1
(en)
|
2010-12-15 |
2012-06-21 |
Kadimastem Ltd. |
Insulin producing cells derived from pluripotent stem cells
|
JP2014501748A
(ja)
|
2010-12-21 |
2014-01-23 |
リコファーマ アーベー |
涙代用物
|
CA2821257C
(en)
|
2010-12-22 |
2020-12-22 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing abiotic stress tolerance, yield, growth rate, vigor, biomass, oil content, and/or nitrogen use efficiency of plants
|
SG191768A1
(en)
|
2010-12-28 |
2013-08-30 |
Kamedis Ltd |
Plant extracts for the treatment and prevention of infections
|
PT3272861T
(pt)
|
2011-01-20 |
2020-03-26 |
Protalix Ltd |
Construção de ácido nucleico para expressão de alfα-galactosidase em plantas e células de plantas
|
US20130316358A1
(en)
|
2011-01-31 |
2013-11-28 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing disease using overlap extension pcr
|
WO2012109600A2
(en)
|
2011-02-11 |
2012-08-16 |
Raindance Technologies, Inc. |
Methods for forming mixed droplets
|
EP2675819B1
(de)
|
2011-02-18 |
2020-04-08 |
Bio-Rad Laboratories, Inc. |
Zusammensetzungen und verfahren für molekulare etikettierung
|
US20130330349A1
(en)
|
2011-02-23 |
2013-12-12 |
Rappaport Family Institute For Research In The Medical Sciences |
High affinity molecules capable of binding a type a plexin receptor and uses of same
|
CN103597078B
(zh)
|
2011-03-02 |
2016-12-14 |
富途锐基尼以色列有限公司 |
具有功能失调的t3ss蛋白的抗菌性转基因植物
|
US9796979B2
(en)
|
2011-03-03 |
2017-10-24 |
Quark Pharmaceuticals Inc. |
Oligonucleotide modulators of the toll-like receptor pathway
|
US9365828B2
(en)
|
2011-03-03 |
2016-06-14 |
Ramot At Tel-Aviv University Ltd. |
Genetically modified muscle cells which express neurotrophic factors
|
WO2012118911A1
(en)
|
2011-03-03 |
2012-09-07 |
Quark Pharmaceuticals, Inc. |
Oligonucleotide modulators of the toll-like receptor pathway
|
AU2012226398B9
(en)
|
2011-03-06 |
2017-04-13 |
Merck Serono S.A. |
Low fucose cell lines and uses thereof
|
US9061006B2
(en)
|
2011-03-08 |
2015-06-23 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for diagnosing and treating phenylketonuria (PKU)
|
JP2014510084A
(ja)
|
2011-03-17 |
2014-04-24 |
ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド |
二重特異性および単一特異性の非対称な抗体ならびにそれらの作製方法
|
WO2012123938A1
(en)
|
2011-03-17 |
2012-09-20 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Quinolone analogs for treating autoimmune diseases
|
EP3483607A1
(de)
|
2011-03-18 |
2019-05-15 |
Stichting VUmc |
Verfahren zur analyse einer blutprobe einer person auf das vorhandensein eines krankheitsmarkers
|
KR101835917B1
(ko)
|
2011-03-22 |
2018-03-07 |
플루리스템 리미티드 |
방사선 또는 화학적 손상을 치료하는 방법들
|
WO2012127475A1
(en)
|
2011-03-24 |
2012-09-27 |
Neurim Pharmaceuticals (1991) Ltd. |
Neuroprotective peptides
|
WO2012131680A2
(en)
|
2011-03-28 |
2012-10-04 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating inflammation
|
WO2012137202A1
(en)
|
2011-04-05 |
2012-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Composition comprising an iron indicator attached to a microparticle and uses of same for quantifying non-transferrin bound iron (ntbi) and cellular labile iron (lci)
|
US8728758B2
(en)
|
2011-04-06 |
2014-05-20 |
Ramot At Tel-Aviv University Ltd. |
Methods of monitoring and analyzing metabolic activity profiles diagnostic and therapeutic uses of same
|
CA2832812C
(en)
|
2011-04-15 |
2017-12-05 |
Pluristem Ltd. |
Methods and systems for harvesting cells
|
GB201106817D0
(en)
|
2011-04-21 |
2011-06-01 |
Astex Therapeutics Ltd |
New compound
|
GB201106814D0
(en)
|
2011-04-21 |
2011-06-01 |
Astex Therapeutics Ltd |
New compounds
|
US9816076B2
(en)
|
2011-05-02 |
2017-11-14 |
Wayne State University |
Protein-induced pluripotent cell technology and uses thereof
|
BR122020018204B1
(pt)
|
2011-05-03 |
2021-11-03 |
Evogene Ltd |
Método para aumentar o rendimento, biomassa, taxa de crescimento, tolerância ao estresse abiótico e/ou eficiência no uso de nitrogênio de uma planta
|
US9192670B2
(en)
|
2011-05-04 |
2015-11-24 |
Ramot At Tel-Aviv University Ltd. |
Regulation of amyloid beta molecular composition for the treatment of alzheimer's disease
|
WO2012153333A1
(en)
|
2011-05-09 |
2012-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Regeneration and repair of mesenchymal tissue using amelogenin
|
WO2012153336A2
(en)
|
2011-05-12 |
2012-11-15 |
Rakuto Bio Technologies Ltd. |
Methods and device for lightening skin complexion
|
WO2012156976A1
(en)
|
2011-05-16 |
2012-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of producing artemisinin in non-host plants and vectors for use in same
|
CA2836503C
(en)
|
2011-05-23 |
2020-09-22 |
Yeda Research And Development Co. Ltd. |
Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
|
WO2012160526A2
(en)
|
2011-05-23 |
2012-11-29 |
Ofir Menashe |
Formulations of microorganism comprising particles and uses of same
|
AU2012264385B2
(en)
|
2011-05-31 |
2018-06-28 |
Hutchison Biofilm Medical Solutions Limited |
Dispersion and detachment of cell aggregates
|
US20140113376A1
(en)
|
2011-06-01 |
2014-04-24 |
Rotem Sorek |
Compositions and methods for downregulating prokaryotic genes
|
US10166295B2
(en)
|
2011-06-02 |
2019-01-01 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
EP3216872B1
(de)
|
2011-06-02 |
2020-04-01 |
Bio-Rad Laboratories, Inc. |
Enzymquantifizierung
|
WO2012172555A1
(en)
|
2011-06-14 |
2012-12-20 |
Yeda Research And Development Co. Ltd. |
Combination therapy to prevent dcis formation and progression to breast cancer
|
KR20140058506A
(ko)
|
2011-06-23 |
2014-05-14 |
카이마 바이오 아그리테크 리미티드 |
부분적으로 또는 완전히 다중화된 게놈을 가지는 보통계 밀 식물 또는 이의 부분물, 이의 하이브리드와 생성물, 및 이를 생성 및 사용하는 방법
|
US8658430B2
(en)
|
2011-07-20 |
2014-02-25 |
Raindance Technologies, Inc. |
Manipulating droplet size
|
MX2014000791A
(es)
|
2011-07-20 |
2014-10-17 |
Kaiima Bio Agritech Ltd |
Plantas de maiz que tienen un genoma parcial o completamente multiplicado y sus usos.
|
EP2550982A1
(de)
|
2011-07-27 |
2013-01-30 |
Technion Research & Development Foundation Ltd. |
Vorrichtungen für chirurgische Anwendungen
|
CN112426538A
(zh)
|
2011-08-04 |
2021-03-02 |
耶达研究及发展有限公司 |
微rna和包含微rna的组合物
|
US9499793B2
(en)
|
2011-08-09 |
2016-11-22 |
Yeda Research And Development Co. Ltd. |
Downregulation of miR-7 for promotion of beta cell differentiation and insulin production
|
US20140212568A1
(en)
|
2011-08-14 |
2014-07-31 |
Kaiimam Bio Agritech Ltd. |
Durum wheat plants having a partially or fully multiplied genome and uses thereof
|
WO2013035070A1
(en)
|
2011-09-07 |
2013-03-14 |
Yeda Research And Development Co. Ltd. |
Olfactory signature and odorant mixture having the same
|
ES2657552T3
(es)
|
2011-09-08 |
2018-03-05 |
Yeda Research And Development Co. Ltd. |
Nuevos biomarcadores de riesgo para el cáncer de pulmón
|
MX351226B
(es)
|
2011-09-08 |
2017-10-05 |
Yeda Res & Dev |
Celulas t con memoria central anti tercera parte, metodos para producirlas y uso de las mismas en transplante y tratamiento de enfermedades.
|
US10760086B2
(en)
|
2011-09-13 |
2020-09-01 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
MX350771B
(es)
|
2011-09-13 |
2017-09-15 |
Monsanto Technology Llc |
Métodos y composiciones para el control de malezas.
|
US9840715B1
(en)
|
2011-09-13 |
2017-12-12 |
Monsanto Technology Llc |
Methods and compositions for delaying senescence and improving disease tolerance and yield in plants
|
US10806146B2
(en)
|
2011-09-13 |
2020-10-20 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10829828B2
(en)
|
2011-09-13 |
2020-11-10 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
UA115535C2
(uk)
|
2011-09-13 |
2017-11-27 |
Монсанто Текнолоджи Ллс |
Спосіб та композиція для боротьби з бур'янами (варіанти)
|
US9416363B2
(en)
|
2011-09-13 |
2016-08-16 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
MX343072B
(es)
|
2011-09-13 |
2016-10-21 |
Monsanto Technology Llc |
Metodos y composiciones para controlar malezas.
|
US9920326B1
(en)
|
2011-09-14 |
2018-03-20 |
Monsanto Technology Llc |
Methods and compositions for increasing invertase activity in plants
|
WO2013054320A1
(en)
|
2011-10-11 |
2013-04-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
|
US9145559B2
(en)
|
2011-10-27 |
2015-09-29 |
Yeda Research And Development Co. Ltd. |
Methods of treating cancer
|
GB201118654D0
(en)
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
GB201118652D0
(en)
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
GB201118675D0
(en)
|
2011-10-28 |
2011-12-14 |
Astex Therapeutics Ltd |
New compounds
|
GB201118656D0
(en)
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
SG11201401648RA
(en)
|
2011-11-03 |
2014-05-29 |
Quark Pharmaceuticals Inc |
Methods and compositions for neuroprotection
|
WO2013070821A1
(en)
|
2011-11-08 |
2013-05-16 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the nervous system
|
US9736998B2
(en)
|
2011-11-23 |
2017-08-22 |
Danziger Dan Flower Farm |
Otomeria plants
|
EP2782930B1
(de)
|
2011-11-27 |
2018-07-11 |
Yeda Research and Development Co. Ltd. |
Verfahren zur angiogeneseregulierung und zusammensetzungen dafür
|
AU2012348574A1
(en)
|
2011-12-08 |
2014-07-24 |
Yeda Research And Development Co. Ltd. |
Mammalian fetal pulmonary cells and therapeutic use of same
|
UA116097C2
(uk)
|
2011-12-11 |
2018-02-12 |
Зе Стейт Оф Ізраел, Міністрі Оф Агрікалче Енд Руерал Девелопмент, Агрікалчерал Рісьоч Організейшн, (А.Р.О.), Волкані Сентре |
Спосіб модуляції провідності устячка рослини
|
WO2013093921A1
(en)
|
2011-12-20 |
2013-06-27 |
Collplant Ltd. |
Collagen coated synthetic polymer fibers
|
EP2794107B1
(de)
|
2011-12-22 |
2021-08-11 |
Life Technologies Corporation |
Sequenzielle lateralfluss-kapillarvorrichtung zur analytbestimmung
|
JP6313219B2
(ja)
|
2011-12-22 |
2018-04-18 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
T細胞/b細胞枯渇化のための特異的プロトコルを使用する安定かつ長期の生着のための併用療法
|
MX2014008083A
(es)
|
2011-12-28 |
2015-03-19 |
Kaiima Bio Agritech Ltd |
Una planta de sorgo cultivada que tiene un genoma parcial o totalmente multiplicado y usos de la misma.
|
SG11201403756PA
(en)
|
2012-01-01 |
2014-11-27 |
Qbi Entpr Ltd |
Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents
|
US20140364484A1
(en)
|
2012-01-12 |
2014-12-11 |
Quark Pharmaceuticals, Inc. |
Combination therapy for treating hearing and balance disorders
|
WO2013114363A2
(en)
|
2012-01-30 |
2013-08-08 |
Yeda Research And Development Co.Ltd. |
Antimicrobial agents
|
US9603907B2
(en)
|
2012-02-01 |
2017-03-28 |
Protalix Ltd. |
Dry powder formulations of dNase I
|
WO2013118120A2
(en)
|
2012-02-06 |
2013-08-15 |
Rosetta Green Ltd. |
Isolated polynucleotides expressing or modulating micrornas or targets of same, transgenic plants comprising same and uses thereof in improving nitrogen use efficiency, abiotic stress tolerance, biomass, vigor or yield of a plant
|
GB201202027D0
(en)
|
2012-02-06 |
2012-03-21 |
Sareum Ltd |
Pharmaceutical compounds
|
EP2814951B1
(de)
|
2012-02-13 |
2019-04-03 |
Gamida-Cell Ltd. |
Kultivierung mesenchymaler stammzellen
|
AU2013219935B2
(en)
|
2012-02-14 |
2016-02-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US20150023929A1
(en)
|
2012-02-19 |
2015-01-22 |
Protalix Ltd. |
Oral unit dosage forms and uses of same for the treatment of gaucher disease
|
EP2844744A2
(de)
|
2012-02-22 |
2015-03-11 |
Brainstem Biotec Ltd. |
Microrns zur erzeugung von astrocyten
|
JP2015509366A
(ja)
|
2012-02-22 |
2015-03-30 |
ブレインステム バイオテック リミテッド |
神経幹細胞および運動ニューロンの生成
|
US20150101074A1
(en)
|
2012-03-01 |
2015-04-09 |
The State of Israel, Ministry of Agriculture & Rural Development, Agriculture Research |
Male sterile garlic plants, hybrid offspring of same and methods of generating and using same
|
US9631028B2
(en)
|
2012-03-07 |
2017-04-25 |
Yeda Research And Development Co. Ltd. |
Compositions for inhibition of quiescin sulfhydryl oxidase (QSOX1) and uses of same
|
EP2828280B1
(de)
|
2012-03-22 |
2018-05-02 |
Ramot at Tel-Aviv University Ltd. |
Multimere plif-peptide und verwendungen davon
|
CA2868238A1
(en)
|
2012-04-18 |
2013-10-24 |
Ramot At Tel Aviv University Ltd. |
Lipidated glycosaminoglycan particles for the delivery of nucleic acids
|
EP2838552A4
(de)
|
2012-04-19 |
2016-05-18 |
Opko Biolog Ltd |
Langwirkende oxyntomodulinvarianten und verfahren zur herstellung davon
|
WO2013160895A1
(en)
|
2012-04-24 |
2013-10-31 |
Biokine Therapeutics Ltd. |
Peptides and use thereof in the treatment of large cell lung cancer
|
ES2627816T3
(es)
|
2012-05-09 |
2017-07-31 |
Yeda Research And Development Co. Ltd. |
Variantes del pro-dominio de tace como inhibidor de TNF-a y su uso médico
|
US8865158B2
(en)
|
2012-05-22 |
2014-10-21 |
Ramot At Tel-Aviv University Ltd. |
Bacteriophages for reducing toxicity of bacteria
|
CA2873828A1
(en)
|
2012-05-24 |
2013-11-28 |
A.B. Seeds Ltd. |
Naked dsrna for silencing target molecules in plant seeds
|
WO2013173923A1
(en)
|
2012-05-25 |
2013-11-28 |
Diamedica, Inc. |
Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
|
GB201209609D0
(en)
|
2012-05-30 |
2012-07-11 |
Astex Therapeutics Ltd |
New compounds
|
GB201209613D0
(en)
|
2012-05-30 |
2012-07-11 |
Astex Therapeutics Ltd |
New compounds
|
EP2855507B1
(de)
|
2012-06-03 |
2018-01-03 |
Ben-Gurion University of The Negev Research and Development Authority |
Funktionalisierte titanbindende peptide und damit beschichtete implantate
|
CA2875599C
(en)
|
2012-06-04 |
2020-08-18 |
Opko Biologics Ltd. |
Pegylated oxyntomodulin variants
|
HUE032613T2
(en)
|
2012-06-04 |
2017-10-30 |
Diamedica Therapeutics Inc |
Human tissue kallikrein 1 is glycosylated isoforms
|
WO2014006621A1
(en)
|
2012-07-03 |
2014-01-09 |
Nanospun Technologies Ltd. |
Methods and devices for adsorption and biodegradation of petroleum
|
CA2879443A1
(en)
|
2012-07-19 |
2014-01-23 |
Zoetis Llc |
Bovine influenza virus compositions
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
AU2013295770A1
(en)
|
2012-07-27 |
2015-01-29 |
Zoetis Services Llc |
Tick toxin compositions
|
EP3594331A1
(de)
|
2012-07-29 |
2020-01-15 |
Yeda Research and Development Co. Ltd. |
Verwendung des reduktiven glycinpfades zur erzeugung formatotropher und autotropher mikroorganismen
|
JP6340366B2
(ja)
|
2012-07-31 |
2018-06-06 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
運動ニューロン疾患を診断および処置する方法
|
DK2880151T3
(da)
|
2012-08-06 |
2020-08-17 |
Brainstorm Cell Therapeutics Ltd |
Fremgangsmåder til frembringelse af mesenkymale stemceller, som udskiller neurotrofiske faktorer
|
AR092868A1
(es)
|
2012-09-03 |
2015-05-06 |
A B Seeds Ltd |
Metodo para mejorar la tolerancia al estres abiotico de plantas y plantas generadas mediante dicho metodo
|
CN104755632B
(zh)
|
2012-09-06 |
2017-10-03 |
生命技术公司 |
多重y‑str分析
|
ES2872349T3
(es)
|
2012-09-12 |
2021-11-02 |
Quark Pharmaceuticals Inc |
Moléculas de oligonucleótidos bicatenarios para DDIT4 y métodos de uso de las mismas
|
EP2895197B1
(de)
|
2012-09-12 |
2020-02-26 |
Ramot at Tel-Aviv University Ltd. |
Immunpartikel, verfahren zu deren herstellung, und deren verwendung
|
US9611473B2
(en)
|
2012-09-12 |
2017-04-04 |
Quark Pharmaceuticals, Inc. |
Double-stranded nucleic acid compounds
|
DK2895608T3
(en)
|
2012-09-12 |
2019-01-21 |
Quark Pharmaceuticals Inc |
DOUBLE-STRENGTHED OIGONUCLEOTIDE MOLECULES FOR P53 AND PROCEDURES FOR USING IT
|
WO2014057490A1
(en)
|
2012-10-09 |
2014-04-17 |
Ramot At Tel-Aviv University Ltd. |
Methods and kits for predicting prognosis of cancer using soluble mortalin in blood
|
EP2908620A4
(de)
|
2012-10-18 |
2016-07-27 |
Monsanto Technology Llc |
Verfahren und zusammensetzungen zur schädlingsbekämpfung bei pflanzen
|
AU2013336237A1
(en)
|
2012-10-22 |
2015-06-11 |
Sabag-Rfa Ltd |
A system for delivering therapeutic agents into living cells and cells nuclei
|
WO2014068408A2
(en)
|
2012-10-23 |
2014-05-08 |
Caris Life Sciences Switzerland Holdings, S.A.R.L. |
Aptamers and uses thereof
|
US10942184B2
(en)
|
2012-10-23 |
2021-03-09 |
Caris Science, Inc. |
Aptamers and uses thereof
|
WO2014064682A1
(en)
|
2012-10-24 |
2014-05-01 |
Yeda Research And Development Co. Ltd. |
Combinations of epidermal growth factor receptor targeting antibodies for treating cancer
|
US9926564B2
(en)
|
2012-10-29 |
2018-03-27 |
Yeda Research And Development Co. Ltd. |
Aptamers, multimeric aptamers and uses thereof
|
SG10201610223PA
(en)
|
2012-11-20 |
2017-02-27 |
Opko Biolog Ltd |
Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides
|
WO2015079413A2
(en)
|
2013-11-28 |
2015-06-04 |
Yeda Research And Development Co. Ltd. |
Synaptojanin-2 inhibitors and uses thereof
|
IN2014MN02655A
(de)
|
2012-11-29 |
2015-08-21 |
Yeda Res & Dev |
|
AU2013361323B2
(en)
|
2012-12-19 |
2018-09-06 |
Caris Science, Inc. |
Compositions and methods for aptamer screening
|
EP2941488B1
(de)
|
2013-01-01 |
2023-03-22 |
Monsanto Technology LLC |
Verfahren zur einfügung von dsrna in pflanzensamen zur modulation der genexpression
|
US10683505B2
(en)
|
2013-01-01 |
2020-06-16 |
Monsanto Technology Llc |
Methods of introducing dsRNA to plant seeds for modulating gene expression
|
WO2014108850A2
(en)
|
2013-01-09 |
2014-07-17 |
Yeda Research And Development Co. Ltd. |
High throughput transcriptome analysis
|
WO2014108854A1
(en)
|
2013-01-09 |
2014-07-17 |
Fusimab Ltd. |
Monospecific anti-hgf and anti-ang2 antibodies and bispecific anti-hgf/anti-ang2 antibodies
|
CN104937412B
(zh)
|
2013-01-17 |
2018-05-25 |
诺威尔卢斯德克有限公司 |
用于鉴定患者特定驱动突变物的方法和系统
|
US10000767B2
(en)
|
2013-01-28 |
2018-06-19 |
Monsanto Technology Llc |
Methods and compositions for plant pest control
|
US10000737B2
(en)
|
2013-02-04 |
2018-06-19 |
Ramot At Tel-Aviv University Ltd. |
Generation of cytotoxic tumor specific cell lines and uses thereof
|
KR20150108405A
(ko)
|
2013-02-22 |
2015-09-25 |
조에티스 서비시즈 엘엘씨 |
가금류 성능 개선을 위한 성장 인자의 난내 투여
|
WO2014136117A1
(en)
|
2013-03-06 |
2014-09-12 |
Protalix Ltd. |
USE OF PLANT CELLS EXPRESSING A TNFalpha POLYPEPTIDE INHIBITOR IN THERAPY
|
US20160017021A1
(en)
|
2013-03-06 |
2016-01-21 |
Protalix Ltd. |
TNF alpha INHIBITOR POLYPEPTIDES, POLYNUCLEOTIDES ENCODING SAME, CELLS EXPRESSING SAME AND METHODS OF PRODUCING SAME
|
WO2014135984A2
(en)
|
2013-03-07 |
2014-09-12 |
Recopharma Ab |
Glycosylated mucin-immunoglobulin fusion protein coated device
|
WO2014164797A2
(en)
|
2013-03-13 |
2014-10-09 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
MX364458B
(es)
|
2013-03-13 |
2019-04-26 |
Monsanto Technology Llc |
Métodos y composiciones para el control de malezas.
|
US20140283211A1
(en)
|
2013-03-14 |
2014-09-18 |
Monsanto Technology Llc |
Methods and Compositions for Plant Pest Control
|
US10568328B2
(en)
|
2013-03-15 |
2020-02-25 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
WO2014147622A1
(en)
|
2013-03-21 |
2014-09-25 |
Collplant Ltd. |
Compositions comprising collagen and prp for tissue regeneration
|
CA2906314A1
(en)
|
2013-03-24 |
2014-10-02 |
Biolinerx Ltd. |
Methods of treating myeloid leukemia
|
EP2986627B1
(de)
|
2013-04-18 |
2019-04-10 |
Carmel Haifa University Economic Corporation Ltd. |
Inhibitoren des eph-a rezeptors und verwendungen davon
|
RU2015149680A
(ru)
|
2013-04-21 |
2017-05-24 |
Йеда Ресеарч Энд Девелопмент Ко. Лтд. |
Агенты для подавления активности и/или снижения количества bcl-xl и/или bcl-w
|
ES2831424T3
(es)
|
2013-04-23 |
2021-06-08 |
Yeda Res & Dev |
Células madre pluripotentes naif aisladas y métodos para generarlas
|
CN105555796B
(zh)
|
2013-04-25 |
2019-09-17 |
耶达研究及发展有限公司 |
抑制肽对治疗炎性疾病的用途
|
GB201307577D0
(en)
|
2013-04-26 |
2013-06-12 |
Astex Therapeutics Ltd |
New compounds
|
US20140343982A1
(en)
*
|
2013-05-14 |
2014-11-20 |
Landmark Graphics Corporation |
Methods and systems related to workflow mentoring
|
EP2999717B1
(de)
|
2013-05-21 |
2018-08-08 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Behandlung von mastzellen-vermittelten erkrankungen
|
EP3626310A1
(de)
|
2013-05-27 |
2020-03-25 |
Rakuto Bio Technologies Ltd. |
Enzymatisches system mit kosmetischen zusammensetzungen
|
ES2938044T3
(es)
|
2013-06-24 |
2023-04-04 |
Univ Ramot |
Estructura a base de epiplón y sistema de suministro
|
RU2703498C2
(ru)
|
2013-07-19 |
2019-10-17 |
Монсанто Текнолоджи Ллс |
Композиции и способы борьбы с leptinotarsa
|
US9850496B2
(en)
|
2013-07-19 |
2017-12-26 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
WO2015015489A1
(en)
|
2013-07-30 |
2015-02-05 |
Biolinerx Ltd. |
Antibody for treating diabetes and autoimmune diseases
|
WO2015015498A1
(en)
|
2013-07-31 |
2015-02-05 |
Qbi Enterprises Ltd. |
Methods of use of sphingolipid polyalkylamine oligonucleotide compounds
|
US9889200B2
(en)
|
2013-07-31 |
2018-02-13 |
Qbi Enterprises Ltd. |
Sphingolipid-polyalkylamine-oligonucleotide compounds
|
IL228026B
(en)
|
2013-08-19 |
2018-05-31 |
Technion Res & Dev Foundation |
Discovery of genetic sequences using pna sensors and isotachophoresis
|
CN105980615A
(zh)
|
2013-08-28 |
2016-09-28 |
卡里斯生命科学瑞士控股有限公司 |
寡核苷酸探针及其用途
|
US9938316B2
(en)
|
2013-08-29 |
2018-04-10 |
Yeda Research And Development Co. Ltd. |
Selective inhibitors of α2 isoform of Na,K-ATPase and use thereof for reduction of intra-ocular pressure and as cardiotonic agents
|
US20160251410A1
(en)
|
2013-09-03 |
2016-09-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions and methods for expressing recombinant polypeptides
|
IL228284A
(en)
|
2013-09-03 |
2016-12-29 |
Technion Res & Dev Foundation |
Implants from cellular scaffolding and blood vessel stalk
|
WO2015033344A1
(en)
|
2013-09-05 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and kits for inhibiting pathogenicity of group a streptococcus (gas) or group g streptococcus (ggs)
|
WO2015037009A1
(en)
|
2013-09-16 |
2015-03-19 |
Plexicure Ltd. |
Isolated proteins capable of binding plexin-a4 and methods of producing and using same
|
ES2717446T3
(es)
|
2013-09-17 |
2019-06-21 |
Yeda Res & Dev |
Péptidos derivados de ERK y usos de los mismos
|
US20160237404A1
(en)
|
2013-10-01 |
2016-08-18 |
Kadimastem Ltd. |
Directed differentiation of astrocytes from human pluripotent stem cells for use in drug screening and the treatment of amyotrophic laterial sclerosis (als)
|
US11901041B2
(en)
|
2013-10-04 |
2024-02-13 |
Bio-Rad Laboratories, Inc. |
Digital analysis of nucleic acid modification
|
KR20220130254A
(ko)
|
2013-10-21 |
2022-09-26 |
옵코 바이오로직스 리미티드 |
장시간-작용하는 폴리펩티드, 그의 생산 방법, 및 그의 투여 방법
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
EP3060656A1
(de)
|
2013-10-24 |
2016-08-31 |
Yeda Research and Development Co., Ltd. |
Polynukleotide zur codierung von brex-system-polypeptiden und verfahren zur verwendung davon
|
KR20200057108A
(ko)
|
2013-10-25 |
2020-05-25 |
웨인 스테이트 유니버시티 |
단백질-유도 생체내 세포 재프로그래밍을 통한 세포 전환 방법, 시스템 및 조성물
|
AU2014343214B2
(en)
|
2013-10-31 |
2020-04-09 |
Biolinerx Ltd. |
Methods of treating acute myeloid leukemia with a FLT3 mutation
|
AR098295A1
(es)
|
2013-11-04 |
2016-05-26 |
Monsanto Technology Llc |
Composiciones y métodos para controlar infestaciones de plagas y parásitos de los artrópodos
|
GB201320729D0
(en)
|
2013-11-25 |
2014-01-08 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
GB201320732D0
(en)
|
2013-11-25 |
2014-01-08 |
Cancer Rec Tech Ltd |
Methods of chemical synthesis
|
ES2754207T3
(es)
|
2013-11-28 |
2020-04-16 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Inhibidores de la ARN polimerasa I y usos de los mismos
|
EP3074533B1
(de)
|
2013-11-29 |
2021-10-27 |
Technion Research & Development Foundation Limited |
Verfahren und vorrichtung für beschleunigt oberflächenbasierte reaktionen
|
US9885688B2
(en)
|
2013-11-29 |
2018-02-06 |
Technion Research And Development Foundation Limited |
Continuous cell detection by isotachophoresis
|
UA119253C2
(uk)
|
2013-12-10 |
2019-05-27 |
Біолоджикс, Інк. |
Спосіб боротьби із вірусом у кліща varroa та у бджіл
|
CA2933252A1
(en)
*
|
2013-12-10 |
2015-06-18 |
Conexio Genomics Pty Ltd |
Methods and probes for identifying gene alleles
|
US10053712B2
(en)
|
2013-12-10 |
2018-08-21 |
Yeda Research And Development Co. Ltd. |
Use of enzymes which catalyze pyruvate synthesis from formate and acetyl-CoA and bacteria expressing same
|
US9944977B2
(en)
|
2013-12-12 |
2018-04-17 |
Raindance Technologies, Inc. |
Distinguishing rare variations in a nucleic acid sequence from a sample
|
RU2696310C1
(ru)
|
2013-12-20 |
2019-08-01 |
Астекс Терапьютикс Лимитед |
Бициклические гетероциклические соединения и их применение в терапии
|
CN105979770B
(zh)
|
2014-01-15 |
2019-07-05 |
孟山都技术公司 |
用于使用epsps多核苷酸的杂草控制的方法和组合物
|
WO2015114633A1
(en)
|
2014-01-30 |
2015-08-06 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. |
Actin binding peptides and compositions comprising same for inhibiting angiogenes is and treating medical conditions associated with same
|
JP2017506259A
(ja)
|
2014-02-03 |
2017-03-02 |
イッスム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッドYissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
幹細胞を枯渇させるためのカゼインキナーゼi阻害剤の使用
|
CA2936158C
(en)
|
2014-02-05 |
2023-06-13 |
Yeda Research And Development Co. Ltd. |
Use of mir-135 or precursor thereof for the treatment and diagnosis of a bipolar disease
|
US10066014B2
(en)
|
2014-02-06 |
2018-09-04 |
Yeda Research And Development Co. Ltd. |
Anti CD84 antibodies, compositions comprising same and uses thereof
|
US20170101633A1
(en)
|
2014-02-10 |
2017-04-13 |
Protalix Ltd. |
Method of maintaining disease stability in a subject having gaucher's disease
|
US10564149B2
(en)
|
2014-02-11 |
2020-02-18 |
Brainstorm Cell Therapeutics Ltd. |
Populations of mesenchymal stem cells that secrete neurotrophic factors
|
CN106255882A
(zh)
|
2014-03-03 |
2016-12-21 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
用于检测铜绿假单胞菌的方法和装置
|
JO3512B1
(ar)
|
2014-03-26 |
2020-07-05 |
Astex Therapeutics Ltd |
مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
|
CN106456648B
(zh)
|
2014-03-26 |
2021-11-02 |
阿斯特克斯治疗有限公司 |
Fgfr抑制剂和igf1r抑制剂的组合
|
RS61536B1
(sr)
|
2014-03-26 |
2021-04-29 |
Astex Therapeutics Ltd |
Kombinacije fgfr- i cmet-inhibitora za lečenje kancera
|
EP2923709A1
(de)
|
2014-03-28 |
2015-09-30 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Mehrstufiger Mehrkomponenten-Malariaimpfstoff
|
CN110506752B
(zh)
|
2014-04-01 |
2022-02-18 |
孟山都技术公司 |
用于控制虫害的组合物和方法
|
US11433163B2
(en)
|
2014-04-10 |
2022-09-06 |
Bonus Therapeutics Ltd. |
Bone repair compositions
|
EP3132055A2
(de)
|
2014-04-14 |
2017-02-22 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Verfahren und kit zur bestimmung des gewebe- oder zellursprungs von dna
|
ES2764504T3
(es)
|
2014-04-17 |
2020-06-03 |
Yeda Res & Dev |
Métodos y equipos para analizar restos de unión al ADN fijados al ADN
|
SG11201608772UA
(en)
|
2014-04-27 |
2016-11-29 |
Ccam Biotherapeutics Ltd |
Humanized antibodies against ceacam1
|
US11427647B2
(en)
|
2014-04-27 |
2022-08-30 |
Famewave Ltd. |
Polynucleotides encoding humanized antibodies against CEACAM1
|
CN106460048B
(zh)
|
2014-04-28 |
2021-01-05 |
耶达研究及发展有限公司 |
针对试剂的微生物组应答
|
BR112016024555A2
(pt)
|
2014-05-04 |
2018-01-23 |
Forrest Innovations Ltd |
composições e métodos de utilização das mesmas para reduzir a resistência contra larvicidas para mosquitos
|
EP3145947A2
(de)
|
2014-05-22 |
2017-03-29 |
Yeda Research and Development Co., Ltd. |
Rekombinante mikroorganismen zur kohlenstofffixierung
|
WO2015186129A1
(en)
|
2014-06-02 |
2015-12-10 |
Technion Research & Development Foundation Limited. |
Compositions and methods of selectively inhibiting irp1 and treating inflammation
|
EP3149155B1
(de)
|
2014-06-02 |
2020-09-23 |
Kadimastem Ltd. |
Verfahren zur induzierung der myelinisierung und reifung von oligodendrozyten
|
WO2015200223A1
(en)
|
2014-06-23 |
2015-12-30 |
Monsanto Technology Llc |
Compositions and methods for regulating gene expression via rna interference
|
EP3145951A1
(de)
|
2014-06-24 |
2017-03-29 |
InSight Biopharmaceuticals Ltd. |
Verfahren zur reinigung von antikörpern
|
US11807857B2
(en)
|
2014-06-25 |
2023-11-07 |
Monsanto Technology Llc |
Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression
|
WO2015198334A2
(en)
|
2014-06-25 |
2015-12-30 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Identification of cancer stem cells and use of same for diagnosis and treatment
|
WO2015198326A1
(en)
|
2014-06-26 |
2015-12-30 |
Ramot At Tel-Aviv University Ltd. |
Liposomal formulations for delivery of nucleic acids
|
WO2016005985A2
(en)
|
2014-07-09 |
2016-01-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for reprogramming cells
|
WO2016009436A1
(en)
|
2014-07-15 |
2016-01-21 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Isolated polypeptides of cd44 and uses thereof
|
JP6700249B2
(ja)
|
2014-07-21 |
2020-06-10 |
ノベルラスディクス リミテッド |
患者特有の変異の薬物応答を測定する方法
|
CA2955414A1
(en)
|
2014-07-21 |
2016-01-28 |
Novellusdx Ltd. |
Methods and systems for determining oncogenic index of patient specific mutations
|
UA125244C2
(uk)
|
2014-07-29 |
2022-02-09 |
Монсанто Текнолоджі Елелсі |
Спосіб умертвіння або припинення росту комахи
|
JP2017525351A
(ja)
|
2014-07-30 |
2017-09-07 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
多能性幹細胞の培養用培地
|
CN111624346A
(zh)
|
2014-08-14 |
2020-09-04 |
米密德诊断学有限公司 |
用于预测及/或决定预后的套组
|
WO2016030899A1
(en)
|
2014-08-28 |
2016-03-03 |
Yeda Research And Development Co. Ltd. |
Methods of treating amyotrophic lateral scleroses
|
JP2017534574A
(ja)
|
2014-09-08 |
2017-11-24 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
チロシンキナーゼ阻害薬(tki)に耐性のがんを処置するための組成物および方法
|
EP2992895A1
(de)
|
2014-09-08 |
2016-03-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Mehrstufiger Dreikomponenten-Malariaimpfstoff
|
CA2959716A1
(en)
|
2014-09-08 |
2016-03-17 |
Yeda Research And Development Co. Ltd. |
Anti-her3 antibodies and uses of same
|
IL234638A0
(en)
|
2014-09-14 |
2014-12-02 |
Yeda Res & Dev |
NMDA receptor antagonists for the treatment of Gaucher disease
|
US10174320B2
(en)
|
2014-09-21 |
2019-01-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Downregulating miR-132 for the treatment of lipid related disorders
|
US10570368B2
(en)
|
2014-11-13 |
2020-02-25 |
Enzootic Holdings Ltd. |
Functional sex-reversal of decapod crustacean females
|
CA2967233A1
(en)
|
2014-11-17 |
2016-05-26 |
Yeda Research And Development Co. Ltd. |
Method of analyzing microbiome
|
US20180042994A1
(en)
|
2014-11-17 |
2018-02-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating diseases related to mitochondrial function
|
BR112017010555A2
(pt)
|
2014-11-20 |
2018-02-27 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
composições e métodos para produção de polipeptídeos com padrão de glicosilação modificado em células vegetais
|
JP6860483B2
(ja)
|
2014-11-26 |
2021-04-14 |
テクノロジー イノベーション モメンタム ファンド(イスラエル)リミテッド パートナーシップTechnology Innovation Momentum Fund(israel)Limited Partnership |
細菌遺伝子の標的化削減
|
US10883111B2
(en)
|
2014-11-27 |
2021-01-05 |
Danziger Innovations Ltd. |
Nucleic acid constructs for genome editing
|
WO2016092555A2
(en)
|
2014-12-11 |
2016-06-16 |
Yeda Research And Development Co. Ltd. |
Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
EP3233099A1
(de)
|
2014-12-17 |
2017-10-25 |
Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. |
Phagentherapie gegen enterokokken
|
WO2016103269A1
(en)
|
2014-12-23 |
2016-06-30 |
Ramot At Tel-Aviv University Ltd. |
Populations of neural progenitor cells and methods of producing and using same
|
CA2972580A1
(en)
|
2014-12-30 |
2016-07-07 |
Cell Cure Neurosciences Ltd. |
Assessing retinal pigment epithelial cell populations
|
AU2015373050B2
(en)
|
2014-12-30 |
2022-09-29 |
Cell Cure Neurosciences Ltd. |
RPE cell populations and methods of generating same
|
RU2017125957A
(ru)
|
2015-01-04 |
2019-02-04 |
Проталикс Лтд. |
Модифицированная днказа и ее применения
|
WO2016116935A1
(en)
|
2015-01-21 |
2016-07-28 |
Yeda Research And Development Co. Ltd. |
Use of rasa2 as a prognostic and therapeutic marker for melanoma
|
US10968449B2
(en)
|
2015-01-22 |
2021-04-06 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
JOP20200201A1
(ar)
|
2015-02-10 |
2017-06-16 |
Astex Therapeutics Ltd |
تركيبات صيدلانية تشتمل على n-(3.5- ثنائي ميثوكسي فينيل)-n'-(1-ميثيل إيثيل)-n-[3-(ميثيل-1h-بيرازول-4-يل) كينوكسالين-6-يل]إيثان-1.2-ثنائي الأمين
|
US20180071280A1
(en)
|
2015-02-26 |
2018-03-15 |
Urifer Ltd. |
Modulators of cell death processes
|
WO2016135732A1
(en)
|
2015-02-26 |
2016-09-01 |
Yeda Research And Development Co. Ltd. |
Method of promoting hair growth
|
AU2016229076B2
(en)
|
2015-03-09 |
2022-01-20 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
EP3268475B1
(de)
|
2015-03-11 |
2020-10-21 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Köderoligonukleotide zur behandlung von krankheiten
|
EP3268380B1
(de)
|
2015-03-12 |
2018-12-26 |
Zoetis Services LLC |
Pyolysinverfahren und -zusammensetzungen
|
IL237852A0
(en)
|
2015-03-19 |
2016-03-24 |
Yeda Res & Dev |
Antibodies against amphigoline, medical preparations containing them and their use
|
US20180064748A1
(en)
|
2015-03-27 |
2018-03-08 |
Yeda Research And Development Co. Ltd. |
Methods of treating motor neuron diseases
|
KR20170132293A
(ko)
|
2015-03-31 |
2017-12-01 |
예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 |
글루타메이트 옥살로아세테이트 트랜스아미나제 1(got1) 제제와 이의 제조방법 및 용도
|
US10960035B2
(en)
|
2015-04-01 |
2021-03-30 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Voleaui Center) |
Erodium crassifolium L'Her plant extracts and uses thereof
|
US10478494B2
(en)
|
2015-04-03 |
2019-11-19 |
Astex Therapeutics Ltd |
FGFR/PD-1 combination therapy for the treatment of cancer
|
DK3280401T3
(da)
|
2015-04-07 |
2021-11-15 |
Ela Pharma Ltd |
Sammensætninger til behandling og/eller forebyggelse af celle- eller vævsnekrose specielt rettet mod kathepsin c og/eller cela1 og/eller cela3a og/eller strukturelt relaterede enzymer dertil
|
EP3081575A1
(de)
|
2015-04-12 |
2016-10-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Anti-plasmodium-parasiten-antikörper
|
WO2016174674A1
(en)
|
2015-04-27 |
2016-11-03 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Egr1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
|
BR112017023448A2
(pt)
|
2015-04-29 |
2018-07-31 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
composições anti-fitopatogênicas
|
US20190031759A1
(en)
|
2015-04-30 |
2019-01-31 |
Technion Research & Development Foundation Limited |
Chimeric antigen receptors and methods of their use
|
EP3292219B9
(de)
|
2015-05-04 |
2022-05-18 |
Ramot at Tel-Aviv University Ltd. |
Verfahren und kits zur fragmentierung von dna
|
WO2016181393A1
(en)
|
2015-05-11 |
2016-11-17 |
Yeda Research And Development Co. Ltd. |
Citrin inhibitors for the treatment of cancer
|
WO2016185471A1
(en)
|
2015-05-17 |
2016-11-24 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Compositions and methods for treating cancer
|
WO2016185457A1
(en)
|
2015-05-19 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Methods of promoting lymphangiogenesis
|
US10849985B2
(en)
|
2015-05-20 |
2020-12-01 |
Yeda Research And Development Co. Ltd. |
Method of targeting senescent cells
|
WO2016185469A1
(en)
|
2015-05-21 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Bacterial populations for promoting health
|
EP3302571B1
(de)
|
2015-05-29 |
2020-11-18 |
OPKO Biologics Ltd. |
Pegylierte oxyntomodulin-varianten
|
UY36703A
(es)
|
2015-06-02 |
2016-12-30 |
Monsanto Technology Llc |
Composiciones y métodos para la administración de un polinucleótido en una planta
|
WO2016196782A1
(en)
|
2015-06-03 |
2016-12-08 |
Monsanto Technology Llc |
Methods and compositions for introducing nucleic acids into plants
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
ES2917884T3
(es)
|
2015-06-18 |
2022-07-12 |
Yeda Res & Dev |
Protocolos de acondicionamiento y uso de los mismos para la regeneración de tejidos
|
WO2016203476A1
(en)
|
2015-06-18 |
2016-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and compositions for diagnosing and treating urothelial cancer
|
ES2893616T3
(es)
|
2015-06-19 |
2022-02-09 |
Opko Biologics Ltd |
Factores de coagulación de acción prolongada y métodos para la producción de los mismos
|
FR3037970B1
(fr)
*
|
2015-06-23 |
2018-11-30 |
Idemia Identity And Security |
Kit de pcr pour l'electrophorese capillaire
|
US10590425B2
(en)
|
2015-06-29 |
2020-03-17 |
Caris Science, Inc. |
Therapeutic oligonucleotides
|
AU2016291825B2
(en)
|
2015-07-16 |
2022-08-11 |
Yeda Research And Development Co. Ltd. |
Genetically modified anti-third party central memory T cells and use of same in immunotherapy
|
WO2017009843A2
(en)
|
2015-07-16 |
2017-01-19 |
Biokine Therapeutics Ltd. |
Compositions, articles of manufacture and methods for treating cancer
|
EP3325494B1
(de)
|
2015-07-19 |
2020-12-30 |
Yeda Research and Development Co., Ltd. |
Selektive inhibitoren der alpha2-haltigen isoformen der na, k-atpase und deren verwendung zur reduzierung des augeninnendruckes
|
WO2017013661A1
(en)
|
2015-07-22 |
2017-01-26 |
Phytopharma International Ltd. |
Bee-ingestible compositions, methods of using same for producing honey and honey produced thereby
|
CA2993652A1
(en)
|
2015-07-28 |
2017-02-02 |
Caris Science, Inc. |
Targeted oligonucleotides
|
US11230696B2
(en)
|
2015-07-29 |
2022-01-25 |
Hadasit Medical Research Services And Development Ltd. |
Large scale production of retinal pigment epithelial cells
|
EP3331546B1
(de)
|
2015-08-03 |
2023-10-04 |
Biokine Therapeutics Ltd. |
Cxcr4-antagonist zur behandlung von krebs
|
WO2017021961A1
(en)
|
2015-08-04 |
2017-02-09 |
Yeda Research And Development Co. Ltd. |
Methods of screening for riboswitches and attenuators
|
EA201890424A1
(ru)
|
2015-08-05 |
2018-06-29 |
Селл Кьюр Нейросайансес Лтд. |
Получение клеток пигментного эпителия сетчатки
|
EA201890442A1
(ru)
|
2015-08-05 |
2018-07-31 |
Селл Кьюр Нейросайансес Лтд. |
Получение фоторецепторов для лечения заболеваний сетчатки
|
EP3334449B1
(de)
|
2015-08-10 |
2021-09-29 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Verfahren und pharmazeutische zusammensetzungen zur verbesserung der wundheilung mithilfe von cd24
|
US20180237790A1
(en)
|
2015-08-13 |
2018-08-23 |
Forrest Innovation Ltd. |
Formulations and compositions for delivery of nucleic acids to plant cells
|
AU2016307935B2
(en)
|
2015-08-14 |
2022-08-18 |
The University Of Melbourne |
Mycoplasma bovis compositions
|
WO2017033188A1
(en)
|
2015-08-24 |
2017-03-02 |
Yeda Research And Development Co. Ltd. |
Algal oil and biofuel and methods of producing same
|
US10765706B2
(en)
|
2015-09-03 |
2020-09-08 |
University Of South Florida |
Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
|
US10647981B1
(en)
|
2015-09-08 |
2020-05-12 |
Bio-Rad Laboratories, Inc. |
Nucleic acid library generation methods and compositions
|
WO2017042814A1
(en)
|
2015-09-10 |
2017-03-16 |
Yeda Research And Development Co. Ltd. |
Use of perforin positive immature dendritic cells in disease treatment
|
DK3353177T3
(da)
|
2015-09-23 |
2020-08-24 |
Janssen Pharmaceutica Nv |
Tricykliske heterocykler til behandling af cancer
|
RU2747644C2
(ru)
|
2015-09-23 |
2021-05-11 |
Янссен Фармацевтика Нв |
Бигетероарил-замещенные 1,4-бензодиазепины и пути их применения для лечения рака
|
GB201517217D0
(en)
|
2015-09-29 |
2015-11-11 |
Astex Therapeutics Ltd And Cancer Res Technology Ltd |
Pharmaceutical compounds
|
CN108473472B
(zh)
|
2015-10-02 |
2021-02-12 |
圣提内尔肿瘤学有限公司 |
作为p70s6激酶抑制剂的2-氨基喹唑啉衍生物
|
WO2017072757A1
(en)
|
2015-10-25 |
2017-05-04 |
Yeda Research And Development Co. Ltd. |
Antibodies targeting quiescin sulfhydryl oxidase (qsox1) and uses of same
|
WO2017072763A1
(en)
|
2015-10-26 |
2017-05-04 |
Cell Cure Neurosciences Ltd. |
Preparation of retinal pigment epithelium cells
|
CA3002767C
(en)
|
2015-10-27 |
2023-03-14 |
Zvi VOGEL |
Compositions comprising cannabidiol and second therapeutic agents for the treatment of cancer
|
IL242380A0
(en)
|
2015-10-29 |
2016-02-01 |
Yeda Res & Dev |
A method for inducing the division of cardiomyocytes and treating heart diseases
|
EP3370791A1
(de)
|
2015-11-03 |
2018-09-12 |
Ariel-University Research and Development Company Ltd. |
Zusammensetzungen zur regeneration und reparatur von nervengewebe
|
WO2017081689A1
(en)
|
2015-11-11 |
2017-05-18 |
Ramot At Tel-Aviv University Ltd. |
Methods of detecting 5-hydroxymethylcytosine and diagnosing of cancer
|
WO2017094001A1
(en)
|
2015-11-30 |
2017-06-08 |
Kadimastem Ltd |
Methods for differentiating and purifying pancreatic endocrine cells
|
EP3176183A1
(de)
|
2015-12-02 |
2017-06-07 |
Yeda Research and Development Co. Ltd |
Zusammensetzungen und verfahren zur behandlung von krebs ohne resistenz gegen einen tyrosinkinasehemmer (tki)
|
WO2017103930A1
(en)
|
2015-12-16 |
2017-06-22 |
Ramot At Tel-Aviv University Ltd. |
Particles comprising decellularized omentum
|
WO2017115367A1
(en)
|
2015-12-28 |
2017-07-06 |
The National Institute for Biotechnology in the Negev Ltd. |
Composition and method for treating amyotrophic lateral sclerosis
|
EP3400068A1
(de)
|
2016-01-06 |
2018-11-14 |
Yeda Research and Development Co., Ltd. |
Zusammensetzungen und verfahren zur behandlung von bösartigen, autoimmun- und entzündungserkrankungen
|
EP3403091B1
(de)
|
2016-01-11 |
2021-12-22 |
Technion Research & Development Foundation Limited |
Verfahren zur bestimmung der prognose von sepsis und behandlung davon
|
BR112018014902A2
(pt)
|
2016-01-21 |
2018-12-18 |
The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo |
plantas partenocárpicas do tipo solanácea, frutos e sementes de uma planta, produtos processados comestíveis, métodos de produção e de reprodução de uma planta,
|
IL243838A
(en)
|
2016-01-28 |
2017-07-31 |
Sp Nano Ltd |
The composition containing sp1 protein and carbon nanoparticles and its uses
|
IL243839B
(en)
|
2016-01-28 |
2018-01-31 |
Sp Nano Ltd |
Conductive wires
|
EP3408376A1
(de)
|
2016-01-31 |
2018-12-05 |
Hadasit Medical Research Services and Development Ltd. |
Autosomale-identische pluripotente stammzellpopulationen mit nicht identischer geschlechtschromosomenzusammensetzung und verwendungen davon
|
JP7072508B2
(ja)
|
2016-02-04 |
2022-05-20 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッド |
変異型p53と関連している疾患、障害または病状の処置におけるペプチドおよびその使用
|
EP3414346B1
(de)
|
2016-02-14 |
2019-11-13 |
Yeda Research and Development Co. Ltd. |
Mikrobiombasierte diagnose, vorhersage und behandlung von rezidivierender fettleibigkeit
|
US20190046497A1
(en)
|
2016-02-14 |
2019-02-14 |
Yeda Research And Development Co., Ltd. |
Methods of modulating protein exocytosis and uses of same in therapy
|
JP2019508422A
(ja)
|
2016-02-16 |
2019-03-28 |
イッスム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッドYissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
シアノバクテリアおよび植物の増殖を阻害するための非タンパク質性フェニルアラニン類似体
|
EP3420075A4
(de)
|
2016-02-23 |
2019-10-16 |
Chaya Brodie |
Erzeugung von krebsstammzellen und verwendung davon
|
RU2756275C2
(ru)
|
2016-03-01 |
2021-09-29 |
Юссум Рисёрч Девелопмент Компани Оф Зэ Хибру Юниверсити Оф Иерусалим Лтд. |
Антитела, специфические к рецептору полиовируса (pvr) человека
|
CN108699609A
(zh)
|
2016-03-03 |
2018-10-23 |
米密德诊断学有限公司 |
分析rna用于诊断感染类型
|
US20190216891A1
(en)
|
2016-03-06 |
2019-07-18 |
Yeda Research And Development Co., Ltd. |
Method for modulating myelination
|
IL244649A0
(en)
|
2016-03-17 |
2016-06-30 |
Yeda Res & Dev |
Methods for the isolation of barrel-like proteases and the identification of peptides that are cleaved by Alidan
|
WO2017161357A1
(en)
|
2016-03-18 |
2017-09-21 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
US10421785B2
(en)
|
2016-04-11 |
2019-09-24 |
Bar-Ilan University |
Delta receptor agonist peptides and use thereof
|
EP3463402B1
(de)
|
2016-05-22 |
2021-06-23 |
Yeda Research and Development Co. Ltd. |
Verfahren zur verwendung von lungenzellen zur transplantation und induktion von toleranz
|
WO2017203526A1
(en)
|
2016-05-23 |
2017-11-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of diagnosing cancer using cancer testis antigens
|
IL245861A0
(en)
|
2016-05-25 |
2016-09-04 |
Yeda Res & Dev |
Use of substances to treat drug-resistant tumors
|
IL298701B2
(en)
|
2016-05-25 |
2024-03-01 |
Caris Science Inc |
Oligonucleotide probes and their uses
|
WO2017208247A1
(en)
|
2016-06-02 |
2017-12-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Assay for the removal of methyl-cytosine residues from dna
|
EP3464322B1
(de)
|
2016-06-05 |
2023-04-05 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Neuartige moleküle zur behandlung von entzündungen
|
WO2017212494A1
(en)
|
2016-06-09 |
2017-12-14 |
Opko Biologics Ltd. |
Long-acting oxyntomodulin formulation and methods of producing and administering same
|
US11859232B2
(en)
|
2016-06-19 |
2024-01-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Screening for chemotherapy resistance in human haploid cells
|
IL246378A0
(en)
|
2016-06-21 |
2016-11-30 |
Technion Res & Dev Foundation |
A hybrid matrix of polymers that adhere to the mucosa and a lipidic drug release system for the treatment of oral cancer
|
US10961504B2
(en)
|
2016-06-27 |
2021-03-30 |
Yeda Research And Development Co. Ltd. |
Veto cells generated from memory T cells
|
EP3482201B1
(de)
|
2016-07-10 |
2022-12-14 |
Memed Diagnostics Ltd. |
Frühe diagnose von infektionen
|
CN109661578B
(zh)
|
2016-07-10 |
2022-05-10 |
米密德诊断学有限公司 |
用于区分细菌和病毒感染的蛋白质特征
|
WO2018011803A1
(en)
|
2016-07-11 |
2018-01-18 |
The National Institute for Biotechnology in the Negev Ltd. |
Fusion proteins with extended serum half life
|
JP7268943B2
(ja)
|
2016-07-11 |
2023-05-08 |
ボーナス セラピューティックス リミテッド |
組織再生のための細胞組成物
|
US20200080050A1
(en)
|
2016-07-11 |
2020-03-12 |
Yaakov Nahmias |
Systems and methods for growing cells in vitro
|
IL246722A0
(en)
|
2016-07-11 |
2016-09-29 |
Yeda Res & Dev |
Combined treatment to increase endogenous synthesis of nitric oxide
|
PT3481855T
(pt)
|
2016-07-11 |
2023-11-27 |
Opko Biologics Ltd |
Fator vii de coagulação de ação prolongada e métodos de produção do mesmo
|
WO2018015881A1
(en)
|
2016-07-18 |
2018-01-25 |
Ramot At Tel-Aviv University Ltd. |
Modular platform for targeted therapeutics
|
US20190203270A1
(en)
|
2016-07-24 |
2019-07-04 |
Yeda Research And Development Co., Ltd. |
Methods and kits for analyzing dna binding moieties attached to dna
|
EP3497231B1
(de)
|
2016-08-08 |
2023-10-04 |
Technology Innovation Momentum Fund (Israel) Limited Partnership |
Bakterielle systeme zur analyse von ubiquitinierten polypeptiden
|
US20190180846A1
(en)
|
2016-08-10 |
2019-06-13 |
Memed Diagnostics Ltd. |
System and method for analysis of biological data
|
US10633706B2
(en)
|
2016-08-10 |
2020-04-28 |
Ramot At Tel-Aviv University Ltd. |
Analysis of methylation status and copy number
|
SG11201901272WA
(en)
|
2016-08-14 |
2019-03-28 |
Univ Ramot |
Mesenchymal cell-derived exosomes to treat neurological disorders
|
IL247368A0
(en)
|
2016-08-18 |
2016-11-30 |
Yeda Res & Dev |
Diagnostic and therapeutic uses of exosomes
|
WO2018037416A1
(en)
|
2016-08-25 |
2018-03-01 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for treating autoimmune diseases
|
IL265100B2
(en)
*
|
2016-08-31 |
2023-11-01 |
Taro Pharma Ind |
Topical formulations of phenoldopam for the treatment of skin problems
|
WO2018047154A1
(en)
|
2016-09-07 |
2018-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Anti-nkp46 antibodies and therapeutic use of same
|
EP3512943B1
(de)
|
2016-09-14 |
2023-04-12 |
Yeda Research and Development Co. Ltd. |
Crisp-seq, integriertes verfahren für massiv parallele einzelzellen-rna-seq und crispr-gepoolte screens
|
WO2018051355A1
(en)
|
2016-09-19 |
2018-03-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Tamoxifen or tamoxifen in combination with arginine/citrulline for the use in the treatment of muscular dystrophy
|
WO2018060998A1
(en)
|
2016-09-29 |
2018-04-05 |
Memed Diagnostics Ltd. |
Methods of prognosis and treatment
|
US11119068B2
(en)
|
2016-10-06 |
2021-09-14 |
Technion Research & Development Foundation Limited |
Device and method for isotachophoretic focusing large sample volumes
|
IL248468A0
(en)
|
2016-10-13 |
2017-01-31 |
Technion Res & Dev Foundation |
Use of caspase-3 inhibitors and caspase-3 activators in the preparation of medical preparations for cancer treatment and wound healing
|
IL248385A0
(en)
|
2016-10-18 |
2017-02-01 |
Yeda Res & Dev |
Treatment of circadian rhythm disorder
|
WO2018087759A1
(en)
|
2016-11-10 |
2018-05-17 |
Yeda Research And Development Co. Ltd. |
Phosphotriesterases for treating or preventing organophosphate exposure associated damage
|
US11542508B2
(en)
|
2016-11-28 |
2023-01-03 |
Yeda Research And Development Co. Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for expressing an expression product of interest
|
US20190343782A1
(en)
|
2016-11-30 |
2019-11-14 |
Yeda Research And Development Co. Ltd. |
Methods of treating liver toxicity and disorders
|
MX2018016003A
(es)
|
2016-12-01 |
2019-05-16 |
Univ Ramot |
Tratamiento combinado para lesiones neurológicas.
|
IL267340B2
(en)
|
2016-12-15 |
2023-12-01 |
Nat Inst Biotechnology Negev Ltd |
Monoclonal antibodies against PCNA and their use
|
US11555178B2
(en)
|
2017-01-18 |
2023-01-17 |
Yeda Research And Development Co. Ltd. |
Genetically modified veto cells and use of same in immunotherapy
|
IL250479A0
(en)
|
2017-02-06 |
2017-03-30 |
Sorek Rotem |
Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
|
IL250799A0
(en)
|
2017-02-26 |
2017-04-30 |
The Nat Inst For Biotechnology In The Negev Ltd |
Soluble chimeras of dr3 and pro-pilot ether and their use
|
IL250916A0
(en)
|
2017-03-02 |
2017-06-29 |
Geiger Benjamin |
Methods for growing t cells in culture and their use
|
CA3054962A1
(en)
|
2017-03-09 |
2018-09-13 |
Rick PAULS |
Dosage forms of tissue kallikrein 1
|
EP3596469A1
(de)
|
2017-03-12 |
2020-01-22 |
Yeda Research and Development Co., Ltd. |
Verfahren zur diagnose und prognose von krebs
|
WO2018167780A1
(en)
|
2017-03-12 |
2018-09-20 |
Yeda Research And Development Co. Ltd. |
Methods of prognosing and treating cancer
|
KR20200031559A
(ko)
|
2017-03-16 |
2020-03-24 |
리니지 셀 테라퓨틱스, 인크. |
망막 질환 요법의 치료 효과를 측정하는 방법
|
EP4317971A3
(de)
|
2017-04-05 |
2024-04-17 |
Yeda Research and Development Co. Ltd |
Ex-vivo-kultursystem und verfahren zur verwendung davon
|
IL252151A0
(en)
|
2017-05-07 |
2017-07-31 |
Fainzilber Michael |
Treatment of stress disorders
|
JP7445429B2
(ja)
|
2017-05-10 |
2024-03-07 |
アリエル サイエンティフィック イノベーションズ リミテッド |
抗体の精製法
|
EP3652541B1
(de)
|
2017-05-21 |
2022-12-14 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Kombination von markern zur diagnose von krebs
|
US20200172604A1
(en)
|
2017-05-23 |
2020-06-04 |
Technion Research & Development Foundation Limited |
Agents which inhibit gads dimerization and methods of use thereof
|
GB201708665D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing extractability of solids from coffee beans
|
EP3630973A1
(de)
|
2017-05-31 |
2020-04-08 |
Tropic Biosciences UK Limited |
Verfahren zur auswahl von zellen mit genomeditierungsereignissen
|
GB201708662D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing shelf-life of banana
|
JOP20190280A1
(ar)
|
2017-06-02 |
2019-12-02 |
Janssen Pharmaceutica Nv |
مثبطات fgfr2 لعلاج سرطان الأوعية الصفراوية
|
WO2018229767A1
(en)
|
2017-06-13 |
2018-12-20 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods for improving cell protein production yields
|
WO2018229764A1
(en)
|
2017-06-13 |
2018-12-20 |
Yeda Research And Development Co. Ltd. |
Treatment of advanced or progressive multiple sclerosis
|
WO2019001419A1
(en)
|
2017-06-27 |
2019-01-03 |
Janssen Pharmaceutica Nv |
NEW COMPOUNDS OF QUINOLEINONE
|
EP4403646A2
(de)
|
2017-07-13 |
2024-07-24 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Dna-ziele als gewebespezifische methylierungsmarker
|
EP3652343A1
(de)
|
2017-07-13 |
2020-05-20 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Digitale tröpfchen-pcr-strategie mit zwei sonden zur spezifischen detektion gewebespezifischer zirkulierender dna-moleküle
|
EP3652342A1
(de)
|
2017-07-13 |
2020-05-20 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Erkennung gewebespezifischer dna
|
US20200140810A1
(en)
|
2017-07-15 |
2020-05-07 |
Aleph Farms |
Cultured meat compositions
|
IL253642A0
(en)
|
2017-07-24 |
2017-09-28 |
Seger Rony |
Combined treatment for cancer
|
IL253984A0
(en)
|
2017-08-14 |
2017-09-28 |
Yeda Res & Dev |
Immunotherapy against aranviruses that bind through transferrin receptor 1 (tfr1
|
US11692166B2
(en)
|
2017-08-23 |
2023-07-04 |
Technion Research & Development Foundation Limited |
Compositions and methods for improving alcohol tolerance in yeast
|
EP3684796A4
(de)
|
2017-09-18 |
2021-06-16 |
B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University |
Succinat-regulierende polypeptide und deren verwendung
|
WO2019058253A1
(en)
|
2017-09-19 |
2019-03-28 |
Tropic Biosciences UK Limited |
MODIFICATION OF THE SPECIFICITY OF NON-CODING RNA MOLECULES FOR SILENCING GENE EXPRESSION IN EUKARYOTIC CELLS
|
IL255664A0
(en)
|
2017-11-14 |
2017-12-31 |
Shachar Idit |
Hematopoietic stem cells with enhanced properties
|
CA3082509A1
(en)
|
2017-11-24 |
2019-05-31 |
Janssen Pharmaceutica Nv |
Pyrazolopyridinone compounds
|
JP7329510B2
(ja)
|
2017-11-24 |
2023-08-18 |
ヤンセン ファーマシューティカ エヌ.ベー. |
ピラゾロピリジノン化合物
|
EP3717032B1
(de)
|
2017-11-29 |
2023-02-15 |
Ramot at Tel-Aviv University Ltd. |
Verfahren zur vorbeugung oder behandlung von neurogenem schock
|
CA3083436A1
(en)
|
2017-11-29 |
2019-06-06 |
Weedout Ltd. |
Compositions, kits and methods for controlling weed of the amaranthus genus
|
WO2019106680A1
(en)
|
2017-12-03 |
2019-06-06 |
Yeda Research And Development Co. Ltd. |
Treatment of an ischemic heart disease
|
EP3723785A1
(de)
|
2017-12-17 |
2020-10-21 |
Yeda Research and Development Co. Ltd |
Komplexe modulatoren des cop9-signalosoms (csn) und deren verwendung
|
EP3731965A1
(de)
|
2017-12-28 |
2020-11-04 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Verfahren zur wiedergabe von biorhythmen auf einem mikrofluidischen chip
|
CN113597312A
(zh)
|
2018-01-25 |
2021-11-02 |
M·里维特 |
用于改善的免疫疗法的方法
|
IL257225A
(en)
|
2018-01-29 |
2018-04-09 |
Yeda Res & Dev |
Treatment of sarcoma
|
IL257269A
(en)
|
2018-01-31 |
2018-04-09 |
Olender Tsviya |
Signaling is directed to the endoplasmic reticulum
|
EP3749689A1
(de)
|
2018-02-08 |
2020-12-16 |
Yeda Research and Development Co. Ltd |
Inhibitoren des 20s-proteasoms
|
EP3921626A4
(de)
|
2018-02-08 |
2022-10-19 |
Phenofast Ltd |
Vorrichtung und verfahren zur echtzeitzellenüberwachung
|
WO2019155465A1
(en)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Methods of identifying and using agents for treating diseases associated with intestinal barrier dysfunction
|
US20210087630A1
(en)
|
2018-02-18 |
2021-03-25 |
Yissum Research Development Company Of The Hebrew University Of Jerusalmem Ltd. |
Cell free dna deconvolusion and use thereof
|
EP3755340A4
(de)
|
2018-02-23 |
2021-11-17 |
Carmel-Haifa University Economic Corporation Ltd. |
Verfahren zur behandlung von gedächtnisstörungen und kognitiver dysfunktion
|
EP3759493A1
(de)
|
2018-02-28 |
2021-01-06 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Verfahren zur diagnose und behandlung von blasenkrebs
|
EP3765034A1
(de)
|
2018-03-12 |
2021-01-20 |
Yeda Research and Development Co. Ltd |
Behandlung einer herzkrankheit
|
US11781183B2
(en)
|
2018-03-13 |
2023-10-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Diagnostic use of cell free DNA chromatin immunoprecipitation
|
CA3093647A1
(en)
|
2018-03-15 |
2019-09-19 |
Biond Biologics Ltd. |
Methods and compositions for decreasing soluble immune receptor cd28
|
JP7518498B2
(ja)
|
2018-03-29 |
2024-07-18 |
テクニオン・リサーチ・アンド・ディベロップメント・ファウンデーション・リミテッド |
Pten阻害剤を含む小胞およびその使用
|
IL258467A
(en)
|
2018-03-29 |
2018-07-04 |
Ilana Kolodkin Gal |
Methods of disrupting a biofilm and/or preventing formation of same
|
EP3774047A1
(de)
|
2018-03-29 |
2021-02-17 |
Yeda Research and Development Co. Ltd |
Verwendung von elektrischen feldgradienten zur kontrolle der genexpression
|
EP3773677A1
(de)
|
2018-04-12 |
2021-02-17 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Anti-aging-zusammensetzungen und verfahren zur verwendung
|
EP3788626A1
(de)
|
2018-04-29 |
2021-03-10 |
Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. |
Verfahren zur auswahl einer patientenspezifischen therapie
|
GB201807192D0
(en)
|
2018-05-01 |
2018-06-13 |
Tropic Biosciences Uk Ltd |
Compositions and methods for reducing caffeine content in coffee beans
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neo-antigens
|
WO2019220441A1
(en)
|
2018-05-15 |
2019-11-21 |
Hadasit Medical Research Services And Development Ltd. |
Compositions and methods for treating cancer resistant to an anti-cancer agent
|
AU2019277908A1
(en)
|
2018-05-27 |
2021-01-07 |
Biolinerx Ltd. |
AGI-134 combined with a checkpoint inhibitor for the treatment of solid tumors
|
WO2019234754A1
(en)
|
2018-06-07 |
2019-12-12 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Nucleic acid constructs and methods of using same
|
WO2019234750A1
(en)
|
2018-06-07 |
2019-12-12 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Methods of regenerating and transforming cannabis
|
EP3810636A1
(de)
|
2018-06-25 |
2021-04-28 |
Yeda Research and Development Co. Ltd |
Systeme und verfahren zur erhöhung der effizienz von genomeditierung
|
EP3818075A1
(de)
|
2018-07-04 |
2021-05-12 |
Ukko Inc. |
Verfahren zum de-epitoping von weizenproteinen und verwendung davon zur behandlung von zöliakie
|
US20210269860A1
(en)
|
2018-07-08 |
2021-09-02 |
Yeda Research And Development Co. Ltd. |
Person-specific assessment of probiotics responsiveness
|
CA3100961A1
(en)
|
2018-07-11 |
2020-01-16 |
Immunity Pharma Ltd. |
Peptide compounds and therapeutic uses of same
|
BR112021000360A2
(pt)
|
2018-07-11 |
2021-04-13 |
Kahr Medical Ltd. |
Proteína de fusão variante sirpalpha-4-1bbl e métodos de uso da mesma
|
EP3827087A1
(de)
|
2018-07-31 |
2021-06-02 |
CollPlant Ltd. |
Transgenes tabakereignis und verfahren zur detektion und verwendung davon
|
IL261156A
(en)
|
2018-08-14 |
2020-02-27 |
Fass Deborah |
Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
|
US20210169908A1
(en)
|
2018-08-16 |
2021-06-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Treatment for gene reactivation
|
JP2021535100A
(ja)
|
2018-08-24 |
2021-12-16 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
M2マクロファージ極性化を調節する方法及び治療におけるその使用
|
CA3112135A1
(en)
|
2018-09-20 |
2020-03-26 |
Yeda Research And Development Co. Ltd. |
Methods of treating amyotrophic lateral sclerosis
|
KR20210064274A
(ko)
|
2018-09-21 |
2021-06-02 |
얀센 파마슈티카 엔.브이. |
담관암종의 치료
|
US20210338767A1
(en)
|
2018-09-25 |
2021-11-04 |
Biolinerx Ltd. |
Methods of selecting treatment for cxcr4-associated cancer
|
WO2020069029A1
(en)
|
2018-09-26 |
2020-04-02 |
Emendobio Inc. |
Novel crispr nucleases
|
IL262658A
(en)
|
2018-10-28 |
2020-04-30 |
Memorial Sloan Kettering Cancer Center |
Prevention of age related clonal hematopoiesis and diseases associated therewith
|
KR20210091226A
(ko)
|
2018-11-08 |
2021-07-21 |
이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. |
부착 비의존성 세포 및 그 용도
|
IL263184A
(en)
|
2018-11-21 |
2020-05-31 |
Yarden Yosef |
Method of treating cancer and compositions for same
|
IL311084A
(en)
|
2018-11-30 |
2024-04-01 |
Caris Mpi Inc |
New generation molecular characterization
|
EP3902806A4
(de)
|
2018-12-26 |
2022-09-28 |
Janssen Pharmaceutica NV |
Thienopyridinonverbindungen
|
EP3914698A1
(de)
|
2019-01-23 |
2021-12-01 |
Yeda Research and Development Co. Ltd |
Kulturmedien für pluripotente stammzellen
|
IL264768A
(en)
|
2019-02-10 |
2020-08-31 |
Sagi Irit |
ANTI-MATRIX METALLOPROTEINASE 7 (MMP-7) inhibitory antibody and its use
|
IL264854A
(en)
|
2019-02-14 |
2020-08-31 |
Bahat Anat |
Spt5 inhibitors and methods of use thereof
|
WO2020170239A1
(en)
|
2019-02-21 |
2020-08-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of generating organoids for high throughput screening of drugs
|
EP3927378A1
(de)
|
2019-02-21 |
2021-12-29 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Verfahren zur reduktion von arzneimittelinduzierter nephrotoxizität
|
CN113692225B
(zh)
|
2019-03-05 |
2023-04-18 |
以色列农业和农村发展部农业研究组织(范卡尼中心) |
经基因组编辑的鸟类
|
WO2020183322A1
(en)
|
2019-03-08 |
2020-09-17 |
Taro Pharmaceutical Industries Ltd. |
Stable topical compositions of fenoldopam
|
CN113795887A
(zh)
|
2019-03-10 |
2021-12-14 |
阿尔缇玛基因组学公司 |
用于序列判定的方法和系统
|
WO2020183473A1
(en)
|
2019-03-14 |
2020-09-17 |
Biond Biologics Ltd. |
Small shedding blocking agents
|
GB201903521D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
No title
|
GB201903519D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
|
GB201903520D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Bistable type ii opsins and uses thereof
|
WO2020194317A1
(en)
|
2019-03-28 |
2020-10-01 |
Yeda Research And Development Co. Ltd. |
Method of treating lipid-related disorders
|
SG11202109902SA
(en)
|
2019-03-29 |
2021-10-28 |
Janssen Pharmaceutica Nv |
Fgfr tyrosine kinase inhibitors for the treatment of urothelial carcinoma
|
JP2022527482A
(ja)
|
2019-03-29 |
2022-06-02 |
ヤンセン ファーマシューティカ エヌ.ベー. |
尿路上皮癌の治療のためのfgfrチロシンキナーゼ阻害剤
|
EP3946611A2
(de)
|
2019-03-31 |
2022-02-09 |
Yeda Research and Development Co. Ltd |
Antivirale und antitumorale verbindungen
|
EP3947728A1
(de)
|
2019-04-03 |
2022-02-09 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Primer für multiplex-pcr
|
EP3956477A2
(de)
|
2019-04-17 |
2022-02-23 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Marker für die methylierung von krebszellen und verwendung davon
|
IL266433B
(en)
|
2019-05-02 |
2020-11-30 |
Sagi Irit |
Compositions comprising the propeptide of lysyl oxidase and uses thereof
|
US20220220559A1
(en)
|
2019-05-13 |
2022-07-14 |
Yeda Research And Development Co. Ltd. |
Cell-free mirna biomarkers for prognosis and diagnosis of neurodegenerative diseases
|
IL266728B
(en)
|
2019-05-19 |
2020-11-30 |
Yeda Res & Dev |
Identification of recurrent mutant neopeptides
|
JP2022533745A
(ja)
|
2019-05-22 |
2022-07-25 |
ハダシット メディカル リサーチ サービシーズ アンド ディベロップメント リミテッド |
ヒト多能性細胞を培養する方法
|
CA3141995A1
(en)
|
2019-06-12 |
2020-12-17 |
Hadasit Medical Research Services And Development Ltd. |
Methods of generating oligodendrocytes
|
US20220307008A1
(en)
|
2019-06-16 |
2022-09-29 |
Yeda Research And Development Co. Ltd. |
Method for stabilizing intracellular rna
|
WO2020261281A1
(en)
|
2019-06-27 |
2020-12-30 |
Ramot At Tel-Aviv University Ltd. |
Semaphorin 3a antibodies and uses thereof
|
CA3145972A1
(en)
|
2019-07-04 |
2021-01-07 |
Ukko Inc. |
De-epitoped alpha gliadin and use of same for the management of celiac disease and gluten sensitivity
|
US20220267409A1
(en)
|
2019-07-11 |
2022-08-25 |
Kahr Medical Ltd. |
Heterodimers and methods of use thereof
|
WO2021009740A1
(en)
|
2019-07-16 |
2021-01-21 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for the treatment of tuberculosis
|
IL268111A
(en)
|
2019-07-16 |
2021-01-31 |
Fainzilber Michael |
Methods of treating pain
|
WO2021019526A1
(en)
|
2019-07-29 |
2021-02-04 |
Yeda Research And Development Co. Ltd. |
Methods of treating and diagnosing lung cancer
|
US20220298522A1
(en)
|
2019-07-30 |
2022-09-22 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization |
Methods of controlling cannabinoid synthesis in plants or cells and plants and cells produced thereby
|
WO2021028909A1
(en)
|
2019-08-12 |
2021-02-18 |
Yeda Research And Development Co. Ltd. |
Dna repair blood test for predicting response of lung cancer patients to immunotherapy
|
MX2022001841A
(es)
|
2019-08-12 |
2022-08-17 |
Biond Biologics Ltd |
Anticuerpos contra ilt2 y uso de los mismos.
|
US20220295799A1
(en)
|
2019-08-14 |
2022-09-22 |
Lavie Bio Ltd. |
Bacterial strains having fungicidal activity, compositions comprising same and use thereof
|
GB201911928D0
(en)
|
2019-08-20 |
2019-10-02 |
Otsuka Pharma Co Ltd |
Pharmaceutical compounds
|
US20240140988A1
(en)
|
2019-08-22 |
2024-05-02 |
Ariel Scientific Innovations Ltd. |
Scaled-up methods for purifying antibodies
|
WO2021038569A1
(en)
|
2019-08-27 |
2021-03-04 |
Yeda Research And Development Co. Ltd. |
Treatment of bacterial vaginosis
|
WO2021048852A1
(en)
|
2019-09-11 |
2021-03-18 |
Yeda Research And Development Co. Ltd. |
Methods of treating breast cancer
|
WO2021059270A2
(en)
|
2019-09-23 |
2021-04-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
TREATMENT OF GENETIC DISEASES CHARACTERIZED BY UNSTABLE mRNAs
|
IL269674B
(en)
|
2019-09-25 |
2020-08-31 |
Roy Bar Ziv |
Assembling protein complexes on a chip
|
GB201913921D0
(en)
|
2019-09-26 |
2019-11-13 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
IL270306A
(en)
|
2019-10-30 |
2021-05-31 |
Yeda Res & Dev |
Prevention and treatment of pre-myeloid and myeloid malignancies
|
WO2021084526A1
(en)
|
2019-10-31 |
2021-05-06 |
Yeda Research And Development Co. Ltd. |
Engineered autotrophic bacteria for co2 conversion to organic materials
|
CA3160506A1
(en)
|
2019-11-11 |
2021-05-20 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Insect control nanobodies and uses thereof
|
US20230022576A1
(en)
|
2019-11-19 |
2023-01-26 |
Protalix Ltd. |
Removal of constructs from transformed cells
|
IL270800A
(en)
|
2019-11-20 |
2021-05-31 |
Yeda Res & Dev |
A method for treating Alzheimer's disease
|
KR20220130108A
(ko)
|
2019-12-02 |
2022-09-26 |
캐리스 엠피아이, 아이엔씨. |
범-암 백금 반응 예측기
|
IL271656A
(en)
|
2019-12-22 |
2021-06-30 |
Yeda Res & Dev |
System and methods for identifying cells that have undergone genome editing
|
EP4077731A1
(de)
|
2019-12-22 |
2022-10-26 |
Yeda Research and Development Co. Ltd |
Diagnose einer frontotemporalen demenz
|
GB201919219D0
(en)
|
2019-12-23 |
2020-02-05 |
Otsuka Pharma Co Ltd |
Cancer biomarkers
|
IL271778A
(en)
|
2019-12-31 |
2021-06-30 |
Ichilov Tech Ltd |
Methods for treating atopic dermatitis
|
US20230048719A1
(en)
|
2019-12-31 |
2023-02-16 |
Kahr Medical Ltd. |
Methods of culturing t cells with a 4-1bbl fusion polypeptide and uses of same
|
US20230048361A1
(en)
|
2019-12-31 |
2023-02-16 |
Kahr Medical Ltd. |
Methods of culturing t cells and uses of same
|
WO2021137241A1
(en)
|
2020-01-02 |
2021-07-08 |
Edity Therapeutics Ltd. |
Delivery compositions and methods
|
IL272074B1
(en)
|
2020-01-15 |
2024-08-01 |
Immunity Pharma Ltd |
Peptide compounds and their use in methods of treating diseases
|
IL272194A
(en)
|
2020-01-22 |
2021-07-29 |
Yeda Res & Dev |
Multi-target antibodies for use in the treatment of diseases
|
WO2021152584A1
(en)
|
2020-01-28 |
2021-08-05 |
Ariel Scientific Innovations Ltd. |
Methods of analyzing cell membranes
|
WO2021152586A1
(en)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Methods of analyzing microbiome, immunoglobulin profile and physiological state
|
EP4096647A1
(de)
|
2020-01-30 |
2022-12-07 |
Yeda Research and Development Co. Ltd |
Behandlung einer akuten lebererkrankung mit tlr-mik-inhibitoren
|
IL272389A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Kits containing antibodies to PD-L1 and their uses in therapy
|
IL272390A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Cancer treatment methods
|
IL295500A
(en)
|
2020-02-09 |
2022-10-01 |
Nlc Pharma Ltd |
Rapid detection test for sars-cov-2
|
IL272586A
(en)
|
2020-02-10 |
2021-08-31 |
Yeda Res & Dev |
A method for cell cluster analysis
|
TW202140012A
(zh)
|
2020-02-12 |
2021-11-01 |
比利時商健生藥品公司 |
用於治療尿路上皮癌的fgfr酪胺酸激酶抑制劑和抗pd1藥劑
|
CN115103678A
(zh)
|
2020-02-12 |
2022-09-23 |
詹森药业有限公司 |
用于治疗高风险非肌层浸润性膀胱癌的fgfr酪氨酸激酶抑制剂
|
WO2021181388A1
(en)
|
2020-03-09 |
2021-09-16 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of diagnosing and treating p53 mutant cancer
|
US20230127559A1
(en)
|
2020-03-16 |
2023-04-27 |
Yeda Research And Development Co. Ltd. |
Peptide analogs and use of same in treating diseases, disorders or conditions associated with mutant p53 protein
|
BR112022019510A2
(pt)
|
2020-03-29 |
2022-11-16 |
Yeda Res & Dev |
Variantes de beta-glucocerebrosidase para uso no tratamento de doença de gaucher
|
EP4125440A1
(de)
|
2020-03-31 |
2023-02-08 |
Biomuse Ltd. |
Bakterien zur vorbeugung und behandlung von rauchinduzierten lungenschäden
|
WO2021205444A1
(en)
|
2020-04-06 |
2021-10-14 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing cancer and predicting responsiveness to therapy
|
WO2021205453A1
(en)
|
2020-04-07 |
2021-10-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods for nucleic acid detection
|
EP4132479A1
(de)
|
2020-04-07 |
2023-02-15 |
Ramot at Tel-Aviv University Ltd. |
Cannabidiolhaltige zusammensetzungen und verwendungen davon
|
US20230135456A1
(en)
|
2020-04-13 |
2023-05-04 |
Exoprother Medical Ltd. |
Cell-derived vesicles comprising wild-type p53 protein for antiviral therapy
|
WO2021209993A1
(en)
|
2020-04-13 |
2021-10-21 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Use of metabolic regulators for the treatment of covid-19
|
US20210322483A1
(en)
|
2020-04-16 |
2021-10-21 |
Ichilov Tech Ltd. |
Cell-derived particles presenting heterologous cd24 and use thereof in therapy
|
CN115867265A
(zh)
|
2020-05-01 |
2023-03-28 |
耶路撒冷希伯来大学伊萨姆研发有限公司 |
作为抗covid-19药剂的e蛋白通道阻断剂和orf3抑制剂
|
WO2022113069A1
(en)
|
2020-11-24 |
2022-06-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
E protein channel blockers and orf3 inhibitors as anti-covid-19 agents
|
WO2021229577A1
(en)
|
2020-05-12 |
2021-11-18 |
Collplant Ltd. |
Collagen as a delivery tool for metal-based anti-viral agents
|
IL274811B
(en)
|
2020-05-20 |
2021-05-31 |
Yeda Res & Dev |
Spatial information is developed for the analysis of individual cells
|
US20230293530A1
(en)
|
2020-06-24 |
2023-09-21 |
Yeda Research And Development Co. Ltd. |
Agents for sensitizing solid tumors to treatment
|
WO2022013874A1
(en)
|
2020-07-14 |
2022-01-20 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Composition comprising cannabinoids, terpenes, and flavonoids for treating depression
|
IL276599A
(en)
|
2020-08-09 |
2022-03-01 |
Yeda Res & Dev |
T cell receptor unique to mage-a1 and its uses
|
IL276627A
(en)
|
2020-08-10 |
2022-03-01 |
Yeda Res & Dev |
Compositions for diagnosis and treatment of coronavirus infections
|
IL300588A
(en)
|
2020-08-12 |
2023-04-01 |
Biond Biologics Ltd |
Antibodies against ILT-2 and their use
|
US20230309480A1
(en)
|
2020-08-18 |
2023-10-05 |
International Rice Research Institute |
Methods of increasing outcrossing rates in gramineae
|
JP2023539867A
(ja)
|
2020-08-27 |
2023-09-20 |
大塚製薬株式会社 |
Mdm2アンタゴニストを用いた癌治療に関するバイオマーカー
|
WO2022053697A1
(en)
|
2020-09-14 |
2022-03-17 |
Janssen Pharmaceutica Nv |
Fgfr inhibitor combination therapies
|
IL277488A
(en)
|
2020-09-21 |
2022-04-01 |
Yeda Res & Dev |
Weight regulation method
|
WO2022064494A2
(en)
|
2020-09-23 |
2022-03-31 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for treating coronaviral infections
|
GB202015187D0
(en)
|
2020-09-25 |
2020-11-11 |
Sentinel Oncology Ltd |
A pharmaceutical salt
|
IL277743A
(en)
|
2020-10-01 |
2022-04-01 |
Yeda Res & Dev |
A method for diagnosing breast cancer
|
WO2022074646A1
(en)
|
2020-10-05 |
2022-04-14 |
Protalix Ltd. |
Dicer-like knock-out plant cells
|
WO2022074656A1
(en)
|
2020-10-07 |
2022-04-14 |
Protalix Ltd. |
Long-acting dnase
|
EP4228637A1
(de)
|
2020-10-15 |
2023-08-23 |
Yeda Research and Development Co. Ltd |
Verfahren zur behandlung von myeloidmalignitäten
|
IL278401A
(en)
|
2020-10-29 |
2022-05-01 |
Yeda Res & Dev |
Polynucleotides for editing RNA and a method for using them
|
IL302594A
(en)
|
2020-11-09 |
2023-07-01 |
1E Therapeutics Ltd |
Methods based on catalytic sequences for the treatment or prevention of bacterial infections
|
EP4251641A1
(de)
|
2020-11-26 |
2023-10-04 |
Ukko Inc. |
Modifizierte gluteninuntereinheit mit hohem molekulargewicht und verwendungen davon
|
IL279559A
(en)
|
2020-12-17 |
2022-07-01 |
Yeda Res & Dev |
Controlling the ubiquitination process of mlkl for disease treatment
|
KR20230133859A
(ko)
|
2020-12-28 |
2023-09-19 |
1이 테라퓨틱스 엘티디. |
p21 mRNA 표적화 DNA자임
|
WO2022144882A2
(en)
|
2020-12-28 |
2022-07-07 |
1E Therapeutics, Ltd. |
P21 mrna target areas for silencing
|
WO2022144903A1
(en)
|
2021-01-03 |
2022-07-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Cancer driver mutation diagnostics
|
JP2024502377A
(ja)
|
2021-01-10 |
2024-01-18 |
スーパーミート ザ エッセンス オブ ミート リミテッド |
培養肉産業用の多能性幹細胞凝集体及びそれから得られる微小組織
|
WO2022153286A1
(en)
|
2021-01-14 |
2022-07-21 |
Yeda Research And Development Co. Ltd. |
Methods of producing vitamin d
|
MX2023008604A
(es)
|
2021-01-21 |
2023-10-10 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Nanopartículas de arni y métodos de uso de las mismas en agricultura.
|
IL280340B
(en)
|
2021-01-21 |
2022-04-01 |
Yeda Res & Dev |
Antibodies, peptides and their combinations for the treatment and prevention of corona virus infections
|
JP2024506955A
(ja)
|
2021-02-18 |
2024-02-15 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
ワクチンを作製する方法
|
EP4294429A1
(de)
|
2021-02-18 |
2023-12-27 |
Yeda Research and Development Co. Ltd |
Genetisch modifizierte bakterien zur erzeugung von impfstoffen
|
GB202103080D0
(en)
|
2021-03-04 |
2021-04-21 |
Otsuka Pharma Co Ltd |
Cancer biomarkers
|
IL281561A
(en)
|
2021-03-16 |
2022-10-01 |
Yeda Res & Dev |
Methods and devices for growing mouse embryos outside the uterus
|
CA3213424A1
(en)
|
2021-03-30 |
2022-10-06 |
Lior Moshe ZELCBUCH |
Pseudomonas bacteriophage and uses thereof
|
IL282188A
(en)
|
2021-04-08 |
2022-11-01 |
Yeda Res & Dev |
Combined use of ketamine and bretigabine for the treatment of psychiatric disorders
|
KR20240004540A
(ko)
|
2021-04-20 |
2024-01-11 |
비온드 바이오로직스 엘티디 |
세포내 전달 조성물
|
AU2022272135A1
(en)
|
2021-05-12 |
2024-01-04 |
Biomx Ltd. |
Staphylococcus bacteriophage and uses thereof
|
WO2022243467A1
(en)
|
2021-05-19 |
2022-11-24 |
Janssen Pharmaceutica Nv |
Fgfr tyrosine kinase inhibitors for the treatment of advanced solid tumors
|
EP4348265A2
(de)
|
2021-05-25 |
2024-04-10 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Diagnose von autismusspektrumsstörungen durch multiomics-plattform
|
IL283563A
(en)
|
2021-05-30 |
2022-12-01 |
Yeda Res & Dev |
Profiling of amps for the diagnosis, monitoring and treatment of microbiome-related diseases
|
IL309061A
(en)
|
2021-06-06 |
2024-02-01 |
Yeda res & development co ltd |
Combined cancer treatment
|
CN117836402A
(zh)
|
2021-06-13 |
2024-04-05 |
耶路撒冷希伯来大学伊森姆研究发展有限公司 |
重编程人细胞的方法
|
WO2022264076A1
(en)
|
2021-06-16 |
2022-12-22 |
Seedx Technologies Inc. |
Methods of sorting matthiola seeds
|
NL2028466B1
(en)
|
2021-06-16 |
2022-12-21 |
Sakata Holland B V |
Methods of sorting matthiola seeds
|
WO2023275590A1
(en)
|
2021-06-29 |
2023-01-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Detection of phosphoinositides in blood cells as a biomarker for alpha synuclein associated pathologies and a method of treatment of parkinson's disease and the related neurodegenerations
|
CA3223344A1
(en)
|
2021-07-02 |
2023-01-05 |
Tropic Biosciences UK Limited |
Delay or prevention of browning in banana fruit
|
WO2023003809A1
(en)
|
2021-07-18 |
2023-01-26 |
Gamida-Cell Ltd. |
Therapeutic nk cell populations
|
WO2023002492A1
(en)
|
2021-07-22 |
2023-01-26 |
Yeda Research And Development Co. Ltd. |
Codon optimization of nucleic acids
|
KR20240040770A
(ko)
|
2021-08-03 |
2024-03-28 |
제니시티 리미티드 |
조작된 tcr 복합체 및 이의 사용 방법
|
GB202111193D0
(en)
|
2021-08-03 |
2021-09-15 |
Phoremost Ltd |
Pharmaceutical compounds
|
EP4130028A1
(de)
|
2021-08-03 |
2023-02-08 |
Rhazes Therapeutics Ltd |
Manipulierter tcr-komplex und verfahren zur verwendung davon
|
EP4384603A1
(de)
|
2021-08-10 |
2024-06-19 |
Gamida-Cell Ltd. |
Manipulierte nk-zellen, verfahren zu deren herstellung und verwendungen davon
|
US20240279335A1
(en)
|
2021-09-06 |
2024-08-22 |
Biond Biologics Ltd. |
Cd28 shedding blocking agents
|
GB202112865D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to black sigatoka disease in banana
|
GB202112866D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to fusarium wilt in a banana
|
IL286430A
(en)
|
2021-09-14 |
2023-04-01 |
Yeda Res & Dev |
Multispecific antibodies for use in the treatment of diseases
|
TW202333720A
(zh)
|
2021-10-12 |
2023-09-01 |
美商塔里斯生物醫學有限責任公司 |
用於膀胱內施用的厄達替尼調配物及系統
|
IL287372A
(en)
|
2021-10-18 |
2023-05-01 |
Trojan Bio Ltd |
Bifunctional antigen-related molecules
|
IL312140A
(en)
|
2021-10-18 |
2024-06-01 |
Belgian Volition Srl |
Using nanoporous tiling to determine the source of DNA in the bloodstream
|
WO2023079553A1
(en)
|
2021-11-03 |
2023-05-11 |
Biond Biologics Ltd. |
Intracellular delivery compositions
|
AU2022404031A1
(en)
|
2021-12-08 |
2024-07-25 |
Board Of Regents, The University Of Texas System |
Multipotent lung progenitor cells for lung regeneration
|
IL313528A
(en)
|
2021-12-15 |
2024-08-01 |
Immunyx Pharma Ltd |
Inhibitors of neutrophil exocytosis
|
WO2023119301A1
(en)
|
2021-12-26 |
2023-06-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of screening and treating fragile x syndrome
|
WO2023148732A1
(en)
|
2022-02-01 |
2023-08-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for selecting an improved genetically modified plant
|
WO2023157003A1
(en)
|
2022-02-16 |
2023-08-24 |
Yeda Research And Development Co. Ltd. |
Methods for shortening lag phase duration in microorganisms
|
TW202400174A
(zh)
|
2022-02-18 |
2024-01-01 |
美商塔里斯生物醫學有限責任公司 |
用於膀胱內施用的Erdafitinib調配物及滲透系統
|
WO2023195009A1
(en)
|
2022-04-07 |
2023-10-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Genetically modified bacteria and use thereof
|
WO2023209716A1
(en)
|
2022-04-25 |
2023-11-02 |
Biond Biologics Ltd. |
Anti-ilt3 antibodies and use thereof
|
WO2023209708A1
(en)
|
2022-04-25 |
2023-11-02 |
Yeda Research And Development Co. Ltd. |
Compositions for altering cyclic adp-ribose secondary messenger signalling
|
WO2023214405A1
(en)
|
2022-05-01 |
2023-11-09 |
Yeda Research And Development Co. Ltd. |
Reexpression of hnf4a to alleviate cancer-associated cachexia
|
WO2023218450A1
(en)
|
2022-05-09 |
2023-11-16 |
Yeda Research And Development Co. Ltd. |
A commensal fungus and uses thereof
|
WO2023233413A1
(en)
|
2022-06-01 |
2023-12-07 |
Yeda Research And Development Co. Ltd. |
eIF4G1-eIF1 INHIBITORS AND USE THEREOF
|
WO2023238131A1
(en)
|
2022-06-07 |
2023-12-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of treating x-linked genetic diseases
|
WO2023248220A1
(en)
|
2022-06-20 |
2023-12-28 |
Yeda Research And Development Co. Ltd. |
Particles comprising double stranded rna and use of same in agriculture
|
WO2024013742A1
(en)
|
2022-07-11 |
2024-01-18 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Improving adoptive cell transfer therapy (act) treatment
|
WO2024038457A1
(en)
|
2022-08-18 |
2024-02-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
A method for determining the tissue or cell of origin of dna
|
IL300306A
(en)
|
2023-01-30 |
2024-08-01 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Methods for immunotherapy targeted against CD48
|
WO2024170495A1
(en)
|
2023-02-13 |
2024-08-22 |
Janssen Pharmaceutica Nv |
Fgfr tyrosine kinase inhibitors for the treatment of high-risk non-muscle invasive bladder cancer
|
WO2024173377A1
(en)
|
2023-02-13 |
2024-08-22 |
Taris Biomedical Llc |
Erdafitinib for intravesical administration for use in the treatment of bladder cancer
|
WO2024173716A1
(en)
|
2023-02-17 |
2024-08-22 |
Taris Biomedical Llc |
Erdafitinib for intravesical administration for use in the treatment of bladder cancer
|